<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1394" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1394/" /><meta name="ncbi_pagename" content="Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Beckwith-Wiedemann Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/08/11" /><meta name="citation_author" content="Cheryl Shuman" /><meta name="citation_author" content="J Bruce Beckwith" /><meta name="citation_author" content="Rosanna Weksberg" /><meta name="citation_pmid" content="20301568" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1394/" /><meta name="citation_keywords" content="Wiedemann-Beckwith Syndrome" /><meta name="citation_keywords" content="Wiedemann-Beckwith Syndrome" /><meta name="citation_keywords" content="Cyclin-dependent kinase inhibitor 1C" /><meta name="citation_keywords" content="Insulin-like growth factor II" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily KQT member 1" /><meta name="citation_keywords" content="CDKN1C" /><meta name="citation_keywords" content="H19" /><meta name="citation_keywords" content="IGF2" /><meta name="citation_keywords" content="KCNQ1" /><meta name="citation_keywords" content="KCNQ1OT1" /><meta name="citation_keywords" content="Beckwith-Wiedemann Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Beckwith-Wiedemann Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Cheryl Shuman" /><meta name="DC.Contributor" content="J Bruce Beckwith" /><meta name="DC.Contributor" content="Rosanna Weksberg" /><meta name="DC.Date" content="2016/08/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1394/" /><meta name="description" content="Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits." /><meta name="og:title" content="Beckwith-Wiedemann Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1394/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bws/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1394/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DC5CCDFC81A7100000000093E044C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1394_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1394_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/barth/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bscl/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1394_"><span class="title" itemprop="name">Beckwith-Wiedemann Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Wiedemann-Beckwith Syndrome</div><p class="contrib-group"><span itemprop="author">Cheryl Shuman</span>, MS, CGC, <span itemprop="author">J Bruce Beckwith</span>, MD, and <span itemprop="author">Rosanna Weksberg</span>, MD, PhD, FRCPC, FCCMG, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK1394_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1394_ai__"><div class="contrib half_rhythm"><span itemprop="author">Cheryl Shuman</span>, MS, CGC<div class="affiliation small">Director, Genetic Counseling<br />The Hospital for Sick Children<br />Program Director, MSc Program<br />Professor, Molecular Genetics<br />University of Toronto<br />Toronto, Ontario</div></div><div class="contrib half_rhythm"><span itemprop="author">J Bruce Beckwith</span>, MD<div class="affiliation small">Department of Pathology and Human Anatomy<br />Loma Linda University<br />Loma Linda, California</div></div><div class="contrib half_rhythm"><span itemprop="author">Rosanna Weksberg</span>, MD, PhD, FRCPC, FCCMG, FACMG<div class="affiliation small">Geneticist, Clinical and Metabolic Genetics<br />Senior Associate Scientist, Research Institute<br />The Hospital for Sick Children<br />Professor, Department of Pediatrics<br />University of Toronto<br />Toronto, Ontario</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 3, 2000</span>; Last Update: <span itemprop="dateModified">August 11, 2016</span>.</p><p><em>Estimated reading time: 39 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bws.Summary" itemprop="description"><h2 id="_bws_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits.</p><p>BWS is considered a clinical spectrum, in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>A provisional diagnosis of BWS based on clinical assessment may be confirmed by molecular/<a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> testing. Cytogenetically detectable abnormalities involving <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15 are found in 1% or fewer of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Molecular genetic testing can identify epigenetic and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> alterations of chromosome 11p15 in individuals with BWS:</p><ul><li class="half_rhythm"><div>Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 2 (IC2) in 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals;</div></li><li class="half_rhythm"><div>Paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15 in 20%; and</div></li><li class="half_rhythm"><div>Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 1 (IC1) in 5%. Methylation alterations associated with deletions or duplications in this region have high heritability.</div></li></ul><p>Sequence analysis of <i>CDKN1C</i> identifies a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> maternally inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in approximately 40% of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases and 5%-10% of cases with no family history of BWS.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment of hypoglycemia to reduce the risk of central nervous system complications; abdominal wall repair for omphalocele; endotracheal intubation for a compromised airway and use of specialized nipples or nasogastric tube feedings to manage feeding difficulties resulting from macroglossia. Children with macroglossia may benefit from tongue reduction surgery in infancy or early childhood and from speech therapy. Surgery may be performed during early puberty to equalize significant differences in leg length secondary to hemihyperplasia; craniofacial surgery may benefit individuals with facial hemihyperplasia. Neoplasias are treated using standard pediatric oncology protocols. Nephrocalcinosis and other renal findings should be assessed and treated by a pediatric nephrologist. Referral of children with structural GI tract anomalies to the relevant specialist; standard management for cardiac problems; standard interventions for children with developmental delay.</p><p><i>Prevention of secondary complications:</i> Prompt evaluation and standard treatment for suspected urinary tract infections to prevent secondary renal damage.</p><p><i>Surveillance:</i> Monitor for hypoglycemia, especially in the neonatal period; screen for embryonal tumors by abdominal ultrasound examination every three months until age eight years; monitor serum alpha-fetoprotein (AFP) concentration every two to three months in the first four years of life for early detection of hepatoblastoma. Annual renal ultrasound examination for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals between age eight years and mid-adolescence to identify those with nephrocalcinosis or medullary sponge kidney disease; consideration of annual or biannual measurement of urinary calcium/creatinine ratio.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Beckwith-Wiedemann syndrome is associated with abnormal regulation of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription in two <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> domains on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5. Most individuals with BWS are reported to have normal chromosome studies or karyotypes. Approximately 85% of individuals with BWS have no family history of BWS; approximately 15% have a family history consistent with parent-of-origin <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission. Children of subfertile parents conceived by assisted reproductive technology (ART) may be at increased risk for <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> disorders, including BWS. Identification of the underlying genetic mechanism causing BWS permits better estimation of <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>. Prenatal screening for pregnancies in the general population that identifies findings suggestive of a diagnosis of BWS may lead to the consideration of chromosome analysis, <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a>, and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Specific prenatal testing is possible by chromosome analysis for families with an inherited chromosome abnormality or by molecular genetic testing for families in which the molecular mechanism of BWS has been defined.</p></div></div><div id="bws.Diagnosis"><h2 id="_bws_Diagnosis_">Diagnosis</h2><div id="bws.Suggestive_Findings"><h3>Suggestive Findings</h3><p>No consensus clinical diagnostic criteria for Beckwith-Wiedemann syndrome (BWS) exist.</p><p>Beckwith-Wiedemann syndrome (BWS) <b>should be suspected</b> in individuals who have one or more of the following major and/or minor findings.</p><p><b>Major findings associated with BWS</b></p><ul><li class="half_rhythm"><div>Macrosomia (traditionally defined as weight and length/height &#x0003e;97th centile)</div></li><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Hemihyperplasia (asymmetric overgrowth of one or more regions of the body)</div></li><li class="half_rhythm"><div>Omphalocele (also called exomphalos) or umbilical hernia</div></li><li class="half_rhythm"><div>Embryonal tumor (e.g., <a href="/books/n/gene/wilms-ov/">Wilms tumor</a>, hepatoblastoma, neuroblastoma, rhabdomyosarcoma) in childhood</div></li><li class="half_rhythm"><div>Visceromegaly involving one or more intra-abdominal organs including liver, spleen, kidneys, adrenal glands, and/or pancreas</div></li><li class="half_rhythm"><div>Cytomegaly of the fetal adrenal cortex (pathognomonic)</div></li><li class="half_rhythm"><div>Renal abnormalities including structural abnormalities, nephromegaly, nephrocalcinosis, and/or later development of medullary sponge kidney</div></li><li class="half_rhythm"><div>Anterior linear ear lobe creases and/or posterior helical ear pits</div></li><li class="half_rhythm"><div>Placental mesenchymal dysplasia [<a class="bk_pop" href="#bws.REF.wilson.2008.137">Wilson et al 2008</a>]</div></li><li class="half_rhythm"><div>Cleft palate (rare in BWS)</div></li><li class="half_rhythm"><div>Cardiomyopathy (rare in BWS)</div></li><li class="half_rhythm"><div>Positive family history (&#x02265;1 family members with a clinical diagnosis of BWS or a history or features suggestive of BWS)</div></li></ul><p><b>Minor findings associated with BWS</b></p><ul><li class="half_rhythm"><div>Pregnancy-related findings including polyhydramnios and prematurity</div></li><li class="half_rhythm"><div>Neonatal hypoglycemia</div></li><li class="half_rhythm"><div>Vascular lesions including nevus simplex (typically appearing on the forehead, glabella, and/or back of the neck) or hemangiomas (cutaneous or extracutaneous)</div></li><li class="half_rhythm"><div>Characteristic facies including midface retrusion and infraorbital creases</div></li><li class="half_rhythm"><div>Structural cardiac anomalies or cardiomegaly</div></li><li class="half_rhythm"><div>Diastasis recti</div></li><li class="half_rhythm"><div>Advanced bone age (common in overgrowth/endocrine disorders)</div></li></ul></div><div id="bws.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of BWS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with either of the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Three major or two major plus at least one minor criteria (see <a href="#bws.Suggestive_Findings">Suggestive Findings</a>)</div><div class="half_rhythm">Note: BWS should be considered a clinical spectrum, with some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals having only one or two suggestive clinical findings. Therefore, the generally accepted clinical criteria proposed here should not be viewed as absolute but rather as guidelines. In other words, they cannot be used to rule out a diagnosis of BWS and cannot substitute for clinical judgment.</div></li><li class="half_rhythm"><div class="half_rhythm">An epigenetic or <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> alteration leading to abnormal <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at 11p15.5 or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> BWS-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in CDKN1C in the presence of one or more clinical findings (see following and <a class="figpopup" href="/books/NBK1394/table/bws.T.genetic_testing_used_in_beckwithwi/?report=objectonly" target="object" rid-figpopup="figbwsTgenetictestingusedinbeckwithwi" rid-ob="figobbwsTgenetictestingusedinbeckwithwi">Table 1</a>).</div></li></ul><p>BWS is associated with abnormal regulation of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription in two <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> domains on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5 (also known as the BWS <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a>). Regulation may be disrupted by any one of numerous mechanisms; a simplified description of known etiologic mechanisms is given here to clarify the testing pipelines described in <a href="#bws.Genetic_Testing">Genetic Testing</a>. See <a href="#bws.Molecular_Pathogenesis">Molecular Pathogenesis</a> for a detailed description of the regulation of gene expression in this region.</p><p>The BWS <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> includes two domains: <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 1 (IC1) regulates the expression of <i>IGF2</i> and <i>H19</i> in <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> 1; imprinting center 2 (IC2) regulates the expression of <i>CDKN1C</i>, <i>KCNQ10T1</i>, and <i>KCNQ1</i> in domain 2 (<a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1</a>). Genomic imprinting is a phenomenon whereby the DNA of the two alleles of a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is differentially modified so that only one parental <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> &#x02013; parent-specific for each gene &#x02013; is normally expressed [<a class="bk_pop" href="#bws.REF.barlow.1994.194">Barlow 1994</a>]. As shown in <a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1a</a>, differential <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of IC1 and IC2 is associated with expression of specific genes on the paternal and maternal alleles in unaffected individuals.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figbwsF1" co-legend-rid="figlgndbwsF1"><a href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figbwsF1" rid-ob="figobbwsF1"><img class="small-thumb" src="/books/NBK1394/bin/bws-Image001.gif" src-large="/books/NBK1394/bin/bws-Image001.jpg" alt="Figure 1. . Map of the BWS locus on 11p15." /></a><div class="icnblk_cntnt" id="figlgndbwsF1"><h4 id="bws.F1"><a href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-ob="figobbwsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Map of the BWS locus on 11p15.5 a) shows a schematic representation of the normal parent of origin-specific imprinted allelic expression. Note: b) and c) show the altered region only. IC = imprinting center, Cen = centromere, Tel = telomere, P = paternal, <a href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-ob="figobbwsF1">(more...)</a></p></div></div><p>Note: IC1 and IC2 are sometimes referred to as differentially methylated regions DMR1 and DMR2, respectively.</p><p>In more than 80% of individuals with BWS, genetic testing can detect one of five alterations [<a class="bk_pop" href="#bws.REF.weksberg.2003.r61">Weksberg et al 2003</a>, <a class="bk_pop" href="#bws.REF.weksberg.2005.12">Weksberg et al 2005</a>]:</p><ul><li class="half_rhythm"><div>A schematic of the following four molecular alterations is shown in <a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1</a>:</div><ul><li class="half_rhythm"><div>Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of IC2 on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> (<a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1b</a>)</div></li><li class="half_rhythm"><div>Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of IC1 on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> (<a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1c</a>)</div></li><li class="half_rhythm"><div>Paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of 11p15.5 (<a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1d</a>)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the maternal <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (<a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1e</a>)</div></li></ul></li><li class="half_rhythm"><div>The following genetic alteration is not represented in <a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1</a>:</div><div>Genomic variants involving <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5 including cytogenetically visible duplications, inversions or translocations, or copy number variants including microduplications or microdeletions of 11p15.5</div></li></ul><p>Note: Methylation changes may be associated with any of the primary <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> variants above except for pathogenic variants on the maternal <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#bws.REF.niemitz.2004.844">Niemitz et al 2004</a>, <a class="bk_pop" href="#bws.REF.sparago.2004.958">Sparago et al 2004</a>, <a class="bk_pop" href="#bws.REF.prawitt.2005.4085">Prawitt et al 2005</a>, <a class="bk_pop" href="#bws.REF.baskin.2014.321">Baskin et al 2014</a>].</p><p><a class="figpopup" href="/books/NBK1394/figure/bws.F2/?report=objectonly" target="object" rid-figpopup="figbwsF2" rid-ob="figobbwsF2">Figure 2</a> summarizes the percentage of individuals with BWS by genetic mechanism.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figbwsF2" co-legend-rid="figlgndbwsF2"><a href="/books/NBK1394/figure/bws.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figbwsF2" rid-ob="figobbwsF2"><img class="small-thumb" src="/books/NBK1394/bin/bws-Image002.gif" src-large="/books/NBK1394/bin/bws-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndbwsF2"><h4 id="bws.F2"><a href="/books/NBK1394/figure/bws.F2/?report=objectonly" target="object" rid-ob="figobbwsF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Causes of Beckwith-Wiedemann syndrome by genetic mechanism *These molecular subgroups, defined by DNA methylation abnormalities, may also be the result of an underlying genomic alteration. Such genomic aberrations are most common for hypermethylation <a href="/books/NBK1394/figure/bws.F2/?report=objectonly" target="object" rid-ob="figobbwsF2">(more...)</a></p></div></div><div id="bws.Genetic_Testing"><h4>Genetic Testing</h4><p>Genetic testing approaches can include <b>DNA</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> studies</b>, <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, <b>copy number analysis for (sequences within) 11p15.5</b>, <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a></b>, <b><a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a></b>, and use of <b>multigene panels</b> that include genes in the BWS <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>DNA <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> studies</b> of IC1 and IC2 should be performed simultaneously.</div><ul><li class="half_rhythm"><div>Methylation alterations at both IC1 and IC2 suggest <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a>.</div></li><li class="half_rhythm"><div>For <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> purposes, further genetic studies can be undertaken to define the mechanism that leads to the <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> abnormality (see <a href="#bws.Genetic_Counseling">Genetic Counseling</a>).</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>CDKN1C</i> should be considered in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases, in individuals with BWS and midline anomalies (cleft palate, posterior fossa abnormalities, omphalocele, or hypospadias [<a class="bk_pop" href="#bws.REF.gardiner.2012.1388">Gardiner et al 2012</a>, <a class="bk_pop" href="#bws.REF.brioude.2015.894">Brioude et al 2015</a>]), or in individuals for whom a strong clinical suspicion for BWS exists but no detectable <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5 <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> abnormalities, copy number variants, <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> abnormalities, or UPD has been identified.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Chromosomal microarray (CMA)</b> using oligonucleotide arrays or SNP <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> arrays can detect a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. CMA may be considered first in a proband with intellectual disability. The ability to size the deletion depends on the type of microarray used and the density of probes in the 11p15.5 region [<a class="bk_pop" href="#bws.REF.keren.2013.546">Keren et al 2013</a>, <a class="bk_pop" href="#bws.REF.baskin.2014.321">Baskin et al 2014</a>, <a class="bk_pop" href="#bws.REF.russo.2016.23">Russo et al 2016</a>]. <a class="def" href="/books/n/gene/glossary/def-item/snp-array/">SNP array</a> analysis can also detect segmental paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Karyotype.</b> A <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> may be considered to test for an inversion or <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> involving 11p15.5. This accounts for fewer than 1% of individuals with BWS.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CDKN1C</i> other genes of interest (see <a href="#bws.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="bws.T.genetic_testing_used_in_beckwithwi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Genetic Testing Used in Beckwith-Wiedemann Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.T.genetic_testing_used_in_beckwithwi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.T.genetic_testing_used_in_beckwithwi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variants/Alterations Detected</th><th id="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of BWS Alterations Detected&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Methylation analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 (maternal)</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC1 (maternal)</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 AND gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at CI1 (paternal UPD)</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis / <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4.&#x000a0;5</sup></td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Heterozygous maternal <i>CDKN1C</i> pathogenic variants</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5% in persons with no family history of BWS&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">~40% in persons with a positive family history of BWS&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Karyotype</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cytogenetic <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, inversion, or <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> of 11p15.5</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microarray (SNP based)</td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microdeletions, microduplications, paternal UPD&#x000a0;<sup>8</sup></td><td headers="hd_h_bws.T.genetic_testing_used_in_beckwithwi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~ 9%&#x000a0;<sup>9</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bws.TF.1.1"><p class="no_margin">Proportion of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals as classified by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, population group, and/or test method, in individuals fulfilling clinical diagnostic criteria for BWS. Note: Frequencies may vary in different populations [<a class="bk_pop" href="#bws.REF.sasaki.2007.1205">Sasaki et al 2007</a>].</p></div></dd><dt>2. </dt><dd><div id="bws.TF.1.2"><p class="no_margin">Assays developed to be <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> sensitive (e.g., multiplex ligation probe analysis [MS-MLPA], <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a> [MS-qPCR], Southern blotting) allow detection of epigenetic and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> alterations of 11p15.5. Methylation-sensitive assays can discern: <br />&#x02013; Microdeletions and microduplications<br />&#x02013; DNA methylation alterations<br />&#x02013; Uniparental disomy (UPD)<br />Interpretation of methylation data should take into account results of <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> analysis because karyotypic abnormalities that alter the relative dosage of parental contributions (e.g., paternal <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>) are associated with abnormal methylation status. Other methods to confirm UPD at 11p15.5 include short tandem repeat (STR) analysis or SNP analysis [<a class="bk_pop" href="#bws.REF.keren.2013.546">Keren et al 2013</a>].</p></div></dd><dt>3. </dt><dd><div id="bws.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#bws.REF.bliek.2001.467">Bliek et al [2001]</a>, <a class="bk_pop" href="#bws.REF.weksberg.2001.2989">Weksberg et al [2001]</a></p></div></dd><dt>4. </dt><dd><div id="bws.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, partial-, whole-, or multigene deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="bws.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="bws.TF.1.6"><p class="no_margin">The detection rate for <i>CDKN1C</i> sequencing varies by family history [<a class="bk_pop" href="#bws.REF.hatada.1997.681">Hatada et al 1997</a>, <a class="bk_pop" href="#bws.REF.lee.1997.304">Lee et al 1997</a>, <a class="bk_pop" href="#bws.REF.okeefe.1997.295">O'Keefe et al 1997</a>, <a class="bk_pop" href="#bws.REF.lam.1999.518">Lam et al 1999</a>, <a class="bk_pop" href="#bws.REF.algar.2000.497">Algar et al 2000</a>, <a class="bk_pop" href="#bws.REF.li.2001.370">Li et al 2001</a>, <a class="bk_pop" href="#bws.REF.brioude.2015.894">Brioude et al 2015</a>].</p></div></dd><dt>7. </dt><dd><div id="bws.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#bws.REF.slavotinek.1997.819">Slavotinek et al [1997]</a>, <a class="bk_pop" href="#bws.REF.li.1998.253">Li et al [1998]</a></p></div></dd><dt>8. </dt><dd><div id="bws.TF.1.8"><p class="no_margin">Paternal UPD occurs by postzygotic somatic <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> and can, therefore, be identified by <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>-only <a class="def" href="/books/n/gene/glossary/def-item/snp-array/">SNP array</a> analysis.</p></div></dd><dt>9. </dt><dd><div id="bws.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#bws.REF.baskin.2014.321">Baskin et al [2014]</a></p></div></dd></dl></div></div></div></div></div></div><div id="bws.Clinical_Characteristics"><h2 id="_bws_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bws.Clinical_Description"><h3>Clinical Description</h3><p>Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have many or only one or two of the characteristic clinical features.</p><p>Incidence figures for the specific individual clinical findings in Beckwith-Wiedemann syndrome (BWS) vary widely in published reports, in part due to ascertainment bias. The following features, however, are clearly part of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b>Prenatal and perinatal.</b> The incidence of polyhydramnios, premature birth, and fetal macrosomia may be as high as 50%. Other common features include a long umbilical cord and an enlarged placenta that averages almost twice the normal weight for gestational age. Placental mesenchymal dysplasia has been reported in babies subsequently found to have features of BWS [<a class="bk_pop" href="#bws.REF.wilson.2008.137">Wilson et al 2008</a>].</p><p>Infants with BWS are at increased risk for mortality mainly as a result of complications of prematurity, macroglossia, hypoglycemia, and, rarely, cardiomyopathy. However, the previously reported mortality rate of 20% may be an overestimate given the recent improvements in syndrome recognition and treatment.</p><p><b>Metabolic abnormalities.</b> Neonatal hypoglycemia is well documented and occurs in approximately 50% of infants with BWS [<a class="bk_pop" href="#bws.REF.mussa.2016a.52">Mussa et al 2016a</a>]. If undetected or untreated, it poses a significant risk for developmental sequelae. Most cases of hypoglycemia are mild and transient; however, in more severe cases hypoglycemia can persist. Delayed onset of hypoglycemia (i.e., in the first month of life) is occasionally observed.</p><p>Other less common endocrine/metabolic/hematologic findings include hypothyroidism, hyperlipidemia/hypercholesterolemia, and polycythemia.</p><p>Hypercalciuria can be found in children with BWS even in the absence of renal abnormalities. On ultrasound examination 22% of individuals with BWS demonstrate nephrocalcinosis as compared to 7%-10% in the general population [<a class="bk_pop" href="#bws.REF.goldman.2003.206">Goldman et al 2003</a>].</p><p><b>Growth.</b> Macroglossia (present in ~90%) and macrosomia (present in ~50%) are generally present at birth, though postnatal onset of both features has also been observed [<a class="bk_pop" href="#bws.REF.chitayat.1990.434">Chitayat et al 1990</a>, <a class="bk_pop" href="#bws.REF.brioude.2013.823">Brioude et al 2013</a>, <a class="bk_pop" href="#bws.REF.ibrahim.2014.11">Ibrahim et al 2014</a>, <a class="bk_pop" href="#bws.REF.mussa.2016b.183">Mussa et al 2016b</a>]. Although most individuals with BWS show rapid growth in early childhood, height typically remains at the upper range of normal. Growth rate usually appears to slow around age seven to eight years.</p><p>Hemihyperplasia* can generally be appreciated at birth, but may become more or less evident as the child grows. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues. When several segments are involved, hemihyperplasia may be limited to one side of the body (ipsilateral) or involve opposite sides of the body (contralateral) [<a class="bk_pop" href="#bws.REF.hoyme.1998.274">Hoyme et al 1998</a>].</p><p>*Note: Hemihyperplasia refers to an abnormality of cell proliferation leading to asymmetric overgrowth; in BWS, hemihyperplasia, referring to increased cell number, has replaced the term hemihypertrophy, which refers to increased cell size.</p><p><b>Neoplasia.</b> Children with BWS are at increased risk for mortality associated with neoplasia, particularly <a href="/books/n/gene/wilms-ov/">Wilms tumor</a> and hepatoblastoma, but also neuroblastoma, adrenocortical carcinoma, and rhabdomyosarcoma. Also seen are a wide variety of other tumors, both malignant and benign [<a class="bk_pop" href="#bws.REF.cohen.2005.287">Cohen 2005</a>]. The estimated risk for tumor development in children with BWS is 7.5% with a range of risks estimated between 4% and 21% [<a class="bk_pop" href="#bws.REF.cohen.2005.287">Cohen 2005</a>, <a class="bk_pop" href="#bws.REF.tan.2006.486">Tan &#x00026; Amor 2006</a>, <a class="bk_pop" href="#bws.REF.mussa.2016a.52">Mussa et al 2016a</a>]. The increased risk for neoplasia appears to be concentrated in the first eight years of life. Tumor development in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals older than age eight years, although uncommon, has been reported.</p><p>Children who have milder phenotypes (e.g., macroglossia and umbilical hernia) may have a somatic form of BWS and may still be at increased risk (compared to the general population) of developing tumors associated with BWS. This is in part because BWS-associated molecular changes may be mosaic; that is, many cells with BWS-associated changes may reside in organs "at risk" for tumor development (e.g., liver or kidneys) but not in tissues that influence clinical presentation. Therefore, the index of suspicion should be high when evaluating children with minimal clinical features in the BWS phenotypic spectrum, with strong consideration of the use of genetic testing to confirm the diagnosis.</p><p><b>Other involved organ systems</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Anterior <b>abdominal wall defects</b> including omphalocele, umbilical hernia, and diastasis recti are common.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Cleft palate</b>, seen in very few individuals with BWS, is typically associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, maternally inherited pathogenic variants in <i>CDKN1C</i> [<a class="bk_pop" href="#bws.REF.hatada.1997.681">Hatada et al 1997</a>, <a class="bk_pop" href="#bws.REF.li.2001.370">Li et al 2001</a>, <a class="bk_pop" href="#bws.REF.mussa.2016c.403">Mussa et al 2016c</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Much of the information regarding <b>cardiovascular problems</b> in BWS is anecdotal. Cardiomegaly is present in approximately 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#bws.REF.pettenati.1986.143">Pettenati et al 1986</a>] and may be detected in infancy if a chest x-ray is performed, but typically resolves without treatment.</div><ul><li class="half_rhythm"><div>Cardiomyopathy has been reported but is rare.</div></li><li class="half_rhythm"><div>Long QT syndrome has been reported in a child with BWS who had a balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> between chromosomes 11 and 17 which interrupted <i>KCNQ1</i> [<a class="bk_pop" href="#bws.REF.kaltenbach.2013.78">Kaltenbach et al 2013</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Renal anomalies</b> can include medullary dysplasia, duplicated collecting system, nephrocalcinosis, medullary sponge kidney, cystic changes, diverticula, and nephromegaly [<a class="bk_pop" href="#bws.REF.choyke.1998.733">Choyke et al 1998</a>, <a class="bk_pop" href="#bws.REF.borer.1999.235">Borer et al 1999</a>, <a class="bk_pop" href="#bws.REF.mussa.2012.397">Mussa et al 2012</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hearing loss</b> is rarely reported in individuals with BWS and is either sensorineural [<a class="bk_pop" href="#bws.REF.kantaputra.2013.192">Kantaputra et al 2013</a>] or conductive due to stapedial fixation [<a class="bk_pop" href="#bws.REF.hopsu.2003.1131">Hopsu et al 2003</a>].</div><div class="half_rhythm">Note: Although parents of children with BWS occasionally raise concerns regarding hearing loss and hypotonia, it is difficult to ascertain whether these and other issues occur with a greater frequency in individuals with BWS compared to the general population rate.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Brain abnormalities</b> involving the posterior fossa have been rarely reported [<a class="bk_pop" href="#bws.REF.gardiner.2012.1388">Gardiner et al 2012</a>, <a class="bk_pop" href="#bws.REF.brioude.2015.894">Brioude et al 2015</a>].</div></li></ul><p><b>Development</b> is usually normal in children with BWS unless there is a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormality, brain malformation, or history of hypoxia or significant untreated hypoglycemia. Neurobehavioral issues such as autism spectrum disorder have been reported with increased frequency in children with BWS ascertained by parental report. However, additional studies including formal neurodevelopmental assessments are needed to assess the frequencies of such problems in BWS.</p><p><b>Adulthood.</b> After childhood, prognosis is generally favorable. However, complications &#x02013; including renal medullary dysplasia and subfertility in males &#x02013; can occur. Such issues may be associated with specific molecular subtypes [<a class="bk_pop" href="#bws.REF.greer.2008.1707">Greer et al 2008</a>].</p></div><div id="bws.Phenotype_Correlations_by_Molecular"><h3>Phenotype Correlations by Molecular Mechanism</h3><p>While general phenotypic correlations by molecular mechanism are provided below, specific clinical outcomes in any individual with BWS cannot be precisely predicted based on the molecular alteration. The remaining variability in individuals with BWS may be due to <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>, genetic background, and/or other unidentified factors.</p><p><b>Neoplasia</b></p><ul><li class="half_rhythm"><div>UPD of 11p15 or gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC1 is associated with the highest risk for Wilms tumor and hepatoblastoma.</div></li><li class="half_rhythm"><div>Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 is associated with a lower risk for tumor development and the tumors reported to date do not include Wilms tumor.</div></li><li class="half_rhythm"><div>Intragenic variants on the maternally derived <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> are associated with:</div><ul><li class="half_rhythm"><div class="half_rhythm">A small number of cases of neuroblastoma [<a class="bk_pop" href="#bws.REF.bliek.2001.467">Bliek et al 2001</a>, <a class="bk_pop" href="#bws.REF.weksberg.2001.2989">Weksberg et al 2001</a>, DeBaun et all 2002, <a class="bk_pop" href="#bws.REF.rump.2005.95">Rump et al 2005</a>, <a class="bk_pop" href="#bws.REF.alsultan.2008.695">Alsultan et al 2008</a>, <a class="bk_pop" href="#bws.REF.kuroiwa.2009.e31">Kuroiwa et al 2009</a>];</div></li><li class="half_rhythm"><div class="half_rhythm">Single cases of ganglioneuroblastoma, acute lymphocytic leukemia, and neuroblastoma in children and melanoma in an adult [<a class="bk_pop" href="#bws.REF.brioude.2015.894">Brioude et al 2015</a>].</div><div class="half_rhythm">Note: Given that leukemia and melanoma occur with some frequency in individuals who do not have BWS, it is difficult to determine whether these single cases represent a coincidental occurrence of two unrelated conditions or if the malignancy was indeed related to BWS.</div></li></ul></li></ul><p><b>Hemihyperplasia</b> is most commonly associated with <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for paternal UPD of 11p15 but is also seen in individuals with molecular alterations at IC2 or IC1 [<a class="bk_pop" href="#bws.REF.debaun.2002.604">DeBaun et al 2002</a>, <a class="bk_pop" href="#bws.REF.shuman.2002">Shuman et al 2002</a>, <a class="bk_pop" href="#bws.REF.enklaar.2006.1">Enklaar et al 2006</a>, <a class="bk_pop" href="#bws.REF.ibrahim.2014.11">Ibrahim et al 2014</a>, <a class="bk_pop" href="#bws.REF.mussa.2016b.183">Mussa et al 2016b</a>].</p><p><b>Positive family history</b> is associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>CDKN1C</i>, deletions at IC1, or (rarely) <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> at IC2 [<a class="bk_pop" href="#bws.REF.weksberg.2004">Weksberg &#x00026; Shuman 2004</a>, <a class="bk_pop" href="#bws.REF.cooper.2005.1025">Cooper et al 2005</a>, <a class="bk_pop" href="#bws.REF.prawitt.2005.4085">Prawitt et al 2005</a>, <a class="bk_pop" href="#bws.REF.enklaar.2006.1">Enklaar et al 2006</a>, <a class="bk_pop" href="#bws.REF.percesepe.2008.447">Percesepe et al 2008</a>, <a class="bk_pop" href="#bws.REF.scott.2008b.106">Scott et al 2008b</a>, <a class="bk_pop" href="#bws.REF.bliek.2009.611">Bliek et al 2009</a>].</p><p><b>Cleft palate</b> is associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants of the maternally derived <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#bws.REF.hatada.1997.681">Hatada et al 1997</a>, <a class="bk_pop" href="#bws.REF.li.2001.370">Li et al 2001</a>].</p><p><b>Omphalocele</b> is primarily associated with alterations at IC2 or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the maternally derived <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#bws.REF.ibrahim.2014.11">Ibrahim et al 2014</a>, <a class="bk_pop" href="#bws.REF.brioude.2015.894">Brioude et al 2015</a>, <a class="bk_pop" href="#bws.REF.mussa.2016a.52">Mussa et al 2016a</a>, <a class="bk_pop" href="#bws.REF.mussa.2016c.403">Mussa et al 2016c</a>].</p><p><b>Macroglossia and macrosomia</b> are prominent features across all molecular subtypes [<a class="bk_pop" href="#bws.REF.ibrahim.2014.11">Ibrahim et al 2014</a>, <a class="bk_pop" href="#bws.REF.mussa.2016b.183">Mussa et al 2016b</a>].</p><p><b>Brain abnormalities</b> involving the posterior fossa are associated with molecular alterations of IC2 or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the maternally inherited <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#bws.REF.gardiner.2012.1388">Gardiner et al 2012</a>, <a class="bk_pop" href="#bws.REF.brioude.2015.894">Brioude et al 2015</a>].</p><p><b>Developmental delay</b> is associated with paternally derived duplications of 11p15 detectable by <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> analysis [<a class="bk_pop" href="#bws.REF.slavotinek.1997.819">Slavotinek et al 1997</a>].</p><p><b>Severe BWS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b> is associated with high levels of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for UPD of 11p15 [<a class="bk_pop" href="#bws.REF.smith.2006.313">Smith et al 2006</a>].</p><p><b>Female monozygotic twinning</b> with discordance for BWS appears to be associated with loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2; male monozygotic twinning occurs far less frequently and is associated with a range of molecular alterations [<a class="bk_pop" href="#bws.REF.weksberg.2002.1317">Weksberg et al 2002</a>, <a class="bk_pop" href="#bws.REF.smith.2006.313">Smith et al 2006</a>].</p><p><b>Subfertility</b> with or without the use of assisted reproductive technologies (ART) appears to be associated with an increased incidence of babies with BWS caused by loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 [<a class="bk_pop" href="#bws.REF.debaun.2003.156">DeBaun et al 2003</a>, <a class="bk_pop" href="#bws.REF.gicquel.2003.1338">Gicquel et al 2003</a>, <a class="bk_pop" href="#bws.REF.maher.2003a.2508">Maher et al 2003a</a>, <a class="bk_pop" href="#bws.REF.maher.2003b.62">Maher et al 2003b</a>, <a class="bk_pop" href="#bws.REF.halliday.2004.526">Halliday et al 2004</a>].</p></div><div id="bws.Penetrance"><h3>Penetrance</h3><p>Penetrance in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases is high if the parent-of-origin effect of <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> domains is considered. For example, a person may inherit a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but have no features of BWS because the <i>CDKN1C</i> pathogenic variant was on the paternally derived <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, which is normally not expressed (i.e., the pathogenic variant is silenced by the normal <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> process).</p></div><div id="bws.Nomenclature"><h3>Nomenclature</h3><p>BWS was originally called EMG, based on the three clinical findings of <i>e</i>xomphalos, <i>m</i>acroglossia, and <i>g</i>igantism.</p></div><div id="bws.Prevalence"><h3>Prevalence</h3><p>The reported prevalence of 1:10,000 [<a class="bk_pop" href="#bws.REF.mussa.2013.2481">Mussa et al 2013</a>] to 1:13,700 [<a class="bk_pop" href="#bws.REF.thorburn.1970.316">Thorburn et al 1970</a>] likely represents an underestimate given the existence of undiagnosed individuals with milder phenotypes.</p><p>BWS has been reported in a wide variety of ethnic populations with an equal incidence in males and females.</p></div></div><div id="bws.Genetically_Related_Allelic_Disorder"><h2 id="_bws_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Molecular alterations at 11p15 including loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2, gain of methylation at IC1 [<a class="bk_pop" href="#bws.REF.martin.2005.129">Martin et al 2005</a>], and 11p15 paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> [<a class="bk_pop" href="#bws.REF.shuman.2002">Shuman et al 2002</a>] have been reported in individuals who have <b>apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hemihyperplasia</b>. Some cases of apparently isolated hemihyperplasia represent the mild end of the clinical spectrum of BWS; however, other cases of isolated hemihyperplasia likely are caused by <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for other molecular alterations.</p><p><b>Isolated</b>
<a href="/books/n/gene/wilms-ov/"><b>Wilms tumor</b></a> can be associated with constitutional alterations of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15 including hypermethylation at IC1, paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of 11p15, and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormalities of 11p15, including deletions and insertions [<a class="bk_pop" href="#bws.REF.scott.2008a.1329">Scott et al 2008a</a>].</p><p>Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at the paternal IC1 is associated with <a href="/books/n/gene/rss/"><b>Silver-Russell syndrome</b></a> and/or <b><a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hemihypoplasia</b> [<a class="bk_pop" href="#bws.REF.zeschnigk.2008.328">Zeschnigk et al 2008</a>, <a class="bk_pop" href="#bws.REF.eggermann.2009.30">Eggermann 2009</a>, <a class="bk_pop" href="#bws.REF.eggermann.2015.77">Eggermann et al 2015</a>].</p><p>A maternally inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CDKN1C</i> leading to increased stability of cyclin-dependent kinase inhibitor 1C was reported in one family with Silver-Russell syndrome [<a class="bk_pop" href="#bws.REF.brioude.2013.823">Brioude et al 2013</a>] and maternally inherited <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>CDKN1C</i> cause <a href="/books/n/gene/image/">IMAGe syndrome</a> [<a class="bk_pop" href="#bws.REF.arboleda.2012.788">Arboleda et al 2012</a>, <a class="bk_pop" href="#bws.REF.milani.2014.169">Milani et al 2014</a>].</p></div><div id="bws.Differential_Diagnosis"><h2 id="_bws_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Overgrowth.</b> Beckwith-Wiedemann syndrome (BWS) is often considered in the differential diagnosis of children presenting with overgrowth. It is important to note the existence of as-yet unclassified overgrowth syndromes that need to be differentiated from BWS. In children considered to have BWS and developmental delay who have a normal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> study and no history of hypoxia or hypoglycemia, other causes of developmental delay need to be considered. If structural or cardiac conduction defects are present, the differential diagnosis should include Simpson-Golabi-Behmel syndrome and Costello syndrome.</p><div id="bws.T.overgrowth_disorders_to_consider_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Overgrowth Disorders to Consider in the Differential Diagnosis of Beckwith-Wiedemann Syndrome (BWS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.T.overgrowth_disorders_to_consider_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.T.overgrowth_disorders_to_consider_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Disorder</th></tr><tr><th headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4" id="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/BWS</th><th headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4" id="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from BWS</th></tr></thead><tbody><tr><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sgbs/">Simpson-Golabi-Behmel syndrome type 1</a></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPC3 GPC4</i></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrosomia</div></li><li class="half_rhythm"><div>Visceromegaly</div></li><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Renal anomalies</div></li><li class="half_rhythm"><div>&#x02191; risk for embryonal tumors</div></li></ul>
</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial features (coarse features, downslanted palpebral fissures, widely spaced eyes, macrostomia, midline groove in the vermilion of lower lip)</div></li><li class="half_rhythm"><div>Cleft lip</div></li><li class="half_rhythm"><div>Structural &#x00026; conduction cardiac abnormalities</div></li><li class="half_rhythm"><div>Skeletal abnormalities incl polydactyly</div></li><li class="half_rhythm"><div>DD</div></li></ul>
</td></tr><tr><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Perlman syndrome<br />(OMIM <a href="http://omim.org/entry/267000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">267000</a>)</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DIS3L2</i></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrosomia</div></li><li class="half_rhythm"><div>High incidence of <a href="/books/n/gene/wilms-ov/">Wilms tumor</a></div></li></ul>
</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial features (micrognathia, low-set ears, depressed nasal bridge, inverted V-shape to vermilion of upper lip)
<ul><li class="half_rhythm"><div>High neonatal mortality</div></li><li class="half_rhythm"><div>Significant ID (common)</div></li></ul>
</td></tr><tr><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/costello/">Costello syndrome</a></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HRAS</i></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Can be similar to BWS in neonatal period (when <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants present w/macrosomia)</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cardiac abnormalities may incl structural defects, hypertrophic cardiomyopathy, or arrhythmias.</div></li><li class="half_rhythm"><div>Failure to thrive</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Coarsening of facial features&#x000a0;<sup>1</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sotos/">Sotos syndrome</a></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSD1</i></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Macrosomia&#x000a0;<sup>3</sup></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial features (dolicocephaly, frontal bossing, downslanted palpebral fissures, pointed chin)</div></li><li class="half_rhythm"><div>Sparse hair in a frontoparietal distribution</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Macrocephaly</div></li></ul>
</td></tr><tr><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mosaic genome-wide paternal uniparental isodisomy&#x000a0;<sup>4</sup></td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple genes</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sporadic</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Large for gestational age</div></li><li class="half_rhythm"><div>Placentomegaly</div></li><li class="half_rhythm"><div>Polyhyramnios</div></li><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Hypoglycemia due to hyperinsulinism</div></li><li class="half_rhythm"><div>Umbilical hernia</div></li><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Hemangioma</div></li><li class="half_rhythm"><div>&#x02191; tumor risk (kidney, liver, adrenal gland)</div></li></ul>
</td><td headers="hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_1_4 hd_h_bws.T.overgrowth_disorders_to_consider_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Features of multiple <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> disorders</div></li><li class="half_rhythm"><div>&#x02191; rate of DD</div></li><li class="half_rhythm"><div>Severity of presentation</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="bws.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#bws.REF.van_eeghen.1999.187">van Eeghen et al [1999]</a></p></div></dd><dt>2. </dt><dd><div id="bws.TF.2.2"><p class="no_margin">Most probands have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div></dd><dt>3. </dt><dd><div id="bws.TF.2.3"><p class="no_margin">If the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of macrosomia is not accompanied by features characteristic of BWS, consideration should be given to testing for <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>NSD1</i> [<a class="bk_pop" href="#bws.REF.baujat.2004.715">Baujat et al 2004</a>].</p></div></dd><dt>4. </dt><dd><div id="bws.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#bws.REF.inbarfeigenberg.2013.13">Inbar-Feigenberg et al [2013]</a>, <a class="bk_pop" href="#bws.REF.kalish.2013.1929">Kalish et al [2013 ]</a></p></div></dd></dl></div></div></div><p><b>Hemihyperplasia or segmental overgrowth</b> can occur as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding or may be associated with other syndromes such as <a href="/books/n/gene/proteus/">Proteus syndrome</a>, <a href="/books/n/gene/phts/"><i>PTEN</i> hamartoma tumor syndrome</a>, Klippel-Trenaunay-Weber syndrome (<a href="http://omim.org/entry/149000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>), and <a href="/books/n/gene/nf1/">neurofibromatosis type 1</a> [<a class="bk_pop" href="#bws.REF.hoyme.1998.274">Hoyme et al 1998</a>]. Asymmetries, such as of the face or chest, should be evaluated to exclude plagiocephaly and chest wall deformities.</p></div><div id="bws.Management"><h2 id="_bws_Management_">Management</h2><div id="bws.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Beckwith-Wiedemann syndrome (BWS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Assessment for airway sufficiency in the presence of macroglossia</div></li><li class="half_rhythm"><div>Evaluation by a feeding specialist if macroglossia causes significant feeding difficulties</div></li><li class="half_rhythm"><div>Assessment of neonates for hypoglycemia; evaluation by a pediatric endocrinologist if hypoglycemia persists beyond the first few days of life.</div></li><li class="half_rhythm"><div>Abdominal ultrasound examination to assess for organomegaly, structural abnormality, and tumors</div></li><li class="half_rhythm"><div>Comprehensive cardiac evaluation including ECG and echocardiogram prior to surgical procedures or when a cardiac abnormality is suspected on clinical evaluation</div></li><li class="half_rhythm"><div>Alpha-fetoprotein assay at the time of initial diagnosis to evaluate for hepatoblastoma. It is important to utilize normal ranges for specific age categories to guide result interpretation, especially in very young infants.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="bws.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Prompt treatment of hypoglycemia to reduce the risk of central nervous system complications. Because onset of hypoglycemia is occasionally delayed for several days, or even months, parents should be informed of the symptoms of hypoglycemia so that they can seek appropriate medical attention.</div></li><li class="half_rhythm"><div>Abdominal wall repair for omphalocele soon after birth. Generally, this surgery is well tolerated.</div></li><li class="half_rhythm"><div>Management of difficulties arising from macroglossia:</div><ul><li class="half_rhythm"><div>Anticipation of difficulties with endotracheal intubation [<a class="bk_pop" href="#bws.REF.kimura.2008.93">Kimura et al 2008</a>]</div></li><li class="half_rhythm"><div>Assessment of respiratory function, possibly including sleep study to address concern regarding potential sleep apnea</div></li><li class="half_rhythm"><div>Management of feeding difficulties using specialized nipples such as the longer nipple recommended for babies with cleft palate or, rarely, short-term use of nasogastric tube feedings</div></li><li class="half_rhythm"><div>Follow up by a craniofacial team including plastic surgeons, orthodontists, and speech pathologists familiar with the natural history of BWS. Tongue growth does slow over time and jaw growth can accelerate to accommodate the enlarged tongue. Some children benefit from tongue reduction surgery; however, surgical reduction typically affects tongue length but not thickness; residual cosmetic and speech issues may require further assessment/treatment [<a class="bk_pop" href="#bws.REF.tomlinson.2007.992">Tomlinson et al 2007</a>].</div></li><li class="half_rhythm"><div>Orthodontic intervention as needed in later childhood/adolescence</div></li><li class="half_rhythm"><div>Assessment of speech difficulties</div></li></ul></li><li class="half_rhythm"><div>Management of cleft palate following standard protocols</div></li><li class="half_rhythm"><div>Referral to a craniofacial surgeon if facial hemihyperplasia is significant</div></li><li class="half_rhythm"><div>Consultation with an orthopedic surgeon if hemihyperplasia results in a significant difference in leg length. Surgery may be necessary during early puberty to close the growth plate of the longer leg in order to equalize the final leg lengths.</div></li><li class="half_rhythm"><div>Treatment of neoplasias following standard pediatric oncology protocols</div></li><li class="half_rhythm"><div>In some individuals with BWS, developmental anomalies of the renal tract are associated with increased calcium excretion and deposition (i.e., nephrocalcinosis). In individuals with evidence of calcium deposits on renal ultrasound examination, assessment for hypercalciuria and a CT scan of the kidneys may be helpful.</div><ul><li class="half_rhythm"><div>Referral to a pediatric nephrologist if urinary calcium is elevated and/or a structural renal anomaly is identified</div></li></ul></li><li class="half_rhythm"><div>Referral of children with structural GI tract abnormalities to the relevant specialist</div></li><li class="half_rhythm"><div>Management of cardiac problems following standard protocols</div></li><li class="half_rhythm"><div>Standard interventions such as infant stimulation programs, occupational and physical therapy, and individualized education programs for children with developmental delay</div></li></ul></div><div id="bws.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Prompt evaluation and standard treatment for suspected urinary tract infections is appropriate to prevent secondary renal damage.</p></div><div id="bws.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Monitoring for hypoglycemia, especially in the neonatal period</div></li><li class="half_rhythm"><div>Screening for embryonal tumors, which has traditionally involved the following (see also Note):</div><ul><li class="half_rhythm"><div class="half_rhythm">Abdominal ultrasound examination every three months until age eight years [<a class="bk_pop" href="#bws.REF.beckwith.1998.268">Beckwith 1998</a>, <a class="bk_pop" href="#bws.REF.tan.2006.486">Tan &#x00026; Amor 2006</a>, <a class="bk_pop" href="#bws.REF.clericuzio.2009.220">Clericuzio &#x00026; Martin 2009</a>, <a class="bk_pop" href="#bws.REF.zarate.2009.1691">Zarate et al 2009</a>]</div></li><li class="half_rhythm"><div class="half_rhythm">Measurement of serum alpha-fetoprotein (AFP) concentration every two to three months in the first four years of life for early detection of hepatoblastoma [<a class="bk_pop" href="#bws.REF.clericuzio.2009.220">Clericuzio &#x00026; Martin 2009</a>]. AFP serum concentration may be elevated in children with BWS in the first year of life [<a class="bk_pop" href="#bws.REF.everman.2000.123">Everman et al 2000</a>]. If the AFP is elevated and imaging reveals no suspicious lesion, follow-up measurement of serum AFP concentration plus baseline liver function tests one month later can be used to determine the trend in serum AFP concentrations over time. If the concentration is not decreasing, it is appropriate to undertake an exhaustive search for an underlying tumor [<a class="bk_pop" href="#bws.REF.clericuzio.2003.270">Clericuzio et al 2003</a>].</div><div class="half_rhythm">Note: (1) Some have proposed revising the tumor surveillance guidelines based on the molecular alteration detected. <a class="bk_pop" href="#bws.REF.scott.2006.995">Scott et al [2006]</a> suggested that children with BWS and IC2 alterations did not require Wilms tumor screening. <a class="bk_pop" href="#bws.REF.brioude.2013.823">Brioude et al [2013]</a> proposed that children with BWS and loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 should have an ultrasound evaluation at the time of clinical diagnosis and only continue with ultrasound surveillance if visceromegaly or "severe" hemihyperplasia are present; otherwise, clinical examination alone was recommended. <a class="bk_pop" href="#bws.REF.mussa.2016b.183">Mussa et al [2016b]</a> questioned the rationale for ultrasound surveillance and "tumor markers" for individuals with loss of methylation at IC2 but subsequently, in their guidelines from the Italian Scientific Committee on BWS, suggested that in the near future, tumor screening in clinical practice will cease. Based on personal experience, the present authors continue to recommend tumor surveillance for all children with BWS regardless of the molecular etiology. (2) Although periodic chest x-ray and urinary VMA and VHA assays to screen for neuroblastoma have been suggested, they have not been incorporated into most screening protocols because of their low yield.</div></li></ul></li><li class="half_rhythm"><div>Annual renal ultrasound examination between age eight years and mid-adolescence to identify those requiring further evaluation for findings such as nephrocalcinosis and medullary sponge kidney disease. Those with positive findings should be referred to a nephrologist for further assessment and follow up. Since the natural history of renal disease in adults has not as yet been evaluated, adult-onset renal disease without early findings remains a possibility. Therefore, consideration should be given to periodic renal evaluation in adulthood.</div></li><li class="half_rhythm"><div>Consideration of annual or biannual measurement of urinary calcium/creatinine ratio from the time of BWS diagnosis as it may be abnormal in individuals with BWS who have normal findings on ultrasound examination [<a class="bk_pop" href="#bws.REF.goldman.2003.206">Goldman et al 2003</a>]</div></li><li class="half_rhythm"><div>Developmental screening as part of routine childcare</div></li></ul></div><div id="bws.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate the newborn sib of an individual with BWS in order to identify as early as possible those who would benefit from initiation of preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Genetic testing if a maternal <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, or cytogenetically visible alteration of 11p15 is known;</div></li><li class="half_rhythm"><div>Monitoring of an at-risk newborn sib for hypoglycemia, even in the absence of obvious clinical findings on prenatal investigation;</div></li><li class="half_rhythm"><div>Strong consideration of tumor surveillance for the apparently unaffected twin of monozygotic twins who are discordant for BWS, given the possibility of shared fetal circulation and resulting <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>.</div></li></ul><p>See <a href="#bws.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bws.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="bws.Genetic_Counseling"><h2 id="_bws_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bws.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Beckwith-Wiedemann syndrome (BWS) is associated with abnormal expression of <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes in the BWS <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> caused by one of several genetic mechanisms.</p></div><div id="bws.Risk_to_Family_Members_of_a_Proband"><h3>Risk to Family Members of a Proband with Normal Chromosomes</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals with BWS do not have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a child with BWS and no known family history of BWS include a medical and family history focused on BWS-associated medical problems in early childhood. Infant and childhood photographs may be useful. Physical examination may be of limited value in adulthood, but ear pits/creases may still be present. Such creases are also not uncommon in the general population.</div></li><li class="half_rhythm"><div>Methylation alterations that are not associated with underlying microdeletions or microduplications are not typically heritable and therefore testing of parents is likely to yield normal <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> findings.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of a child with BWS depends on the genetic basis for BWS in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (<a class="figpopup" href="/books/NBK1394/table/bws.T.risk_to_sibs_of_a_proband_with_bws/?report=objectonly" target="object" rid-figpopup="figbwsTrisktosibsofaprobandwithbws" rid-ob="figobbwsTrisktosibsofaprobandwithbws">Table 3</a>). The majority of families have a <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> of less than 1%; however, certain etiologies involve a recurrence risk as high as 50%.</div></li><li class="half_rhythm"><div>For <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> assessment. The underlying genetic mechanism should be determined for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes (see <a href="#bws.Diagnosis">Diagnosis</a>).</div></li></ul><div id="bws.T.risk_to_sibs_of_a_proband_with_bws" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Risk to Sibs of a Proband with BWS Based on Family History and Molecular Mechanism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.T.risk_to_sibs_of_a_proband_with_bws/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.T.risk_to_sibs_of_a_proband_with_bws_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Family History</th><th id="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">BWS Molecular Mechanism</th><th id="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Risk to Sibs of a Proband</th></tr></thead><tbody><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Negative<br />(normal <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>)<br />(~85%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of IC2 on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> (50%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very low in the absence of a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality (e.g., microdeletion/microduplication [confirmed by MS-MLPA] or pathogenic variants at another <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, such as <i>NLRP2</i>)</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Unknown (~20%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown but empirically low&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of 11p15.5 (~20%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very low because the UPD in this region appears to arise from a postzygotic somatic <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a></td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of IC1 on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> (5%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very low in the absence of a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality (confirmed by MS-MLPA)</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (~5%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Several instances of maternal transmission of a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a clinically unaffected mother to her <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring reported&#x000a0;<sup>2,&#x000a0;3</sup><br />Recurrence risk for such families possibly as high as 50%</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Microdeletion, microduplication (~9%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;50%. When a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality leads to a <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> alteration, molecular testing should be considered for both parents even in the absence of a positive family history.&#x000a0;<sup>4,&#x000a0;5</sup><br />If one parent has the same <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality, parent-of-origin effects must be considered as the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> may be as high as 50%.</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Positive<br />(normal <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>)<br />(~15%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (40%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If the mother has a CDKN1C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is 50%.<br />If the father has a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to sibs is increased but the exact figure must await further empiric studies.<br />If neither parent has the <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to sibs is low; however, <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> is possible.</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> not identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (~60%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;50%</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Microdeletion, microduplication (~9%)</td><td headers="hd_h_bws.T.risk_to_sibs_of_a_proband_with_bws_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;50%. When a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality leads to a <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> alteration, molecular testing should be considered for both parents even in the absence of a positive family history.&#x000a0;<sup>4,&#x000a0;5</sup><br />If one parent has the same <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality, parent-of-origin effects must be considered as the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> may be as high as 50%.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bws.TF.3.1"><p class="no_margin">A proportion of these individuals, especially those with hemihyperplasia, may have <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for UPD 11p15 which may not have been detected because of low levels of the alteration in the tissue sampled. Consideration should be given to testing additional tissues (e.g., skin from the larger side).</p></div></dd><dt>2. </dt><dd><div id="bws.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#bws.REF.hatada.1997.681">Hatada et al [1997]</a>, <a class="bk_pop" href="#bws.REF.okeefe.1997.295">O'Keefe et al [1997]</a>, <a class="bk_pop" href="#bws.REF.lew.2004.268">Lew et al [2004]</a></p></div></dd><dt>3. </dt><dd><div id="bws.TF.3.3"><p class="no_margin">Unexpectedly, one instance of paternal transmission of a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a clinically unaffected father has also been reported [<a class="bk_pop" href="#bws.REF.lee.1997.304">Lee et al 1997</a>].</p></div></dd><dt>4. </dt><dd><div id="bws.TF.3.4"><p class="no_margin">Some <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> defects are associated with microdeletions or microduplications not visible on a high-resolution <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>. Therefore, <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> should be offered in cases of abnormal methylation to identify the small percentage of families with significantly increased <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>.</p></div></dd><dt>5. </dt><dd><div id="bws.TF.3.5"><p class="no_margin">Testing for heritable microdeletions/microduplications should be considered in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases in which a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been detected and the <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> is normal [<a class="bk_pop" href="#bws.REF.niemitz.2004.844">Niemitz et al 2004</a>, <a class="bk_pop" href="#bws.REF.sparago.2004.958">Sparago et al 2004</a>, <a class="bk_pop" href="#bws.REF.prawitt.2005.4085">Prawitt et al 2005</a>].</p></div></dd></dl></div></div></div><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><div id="bws.T.risk_to_offspring_of_a_proband_wit" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Risk to Offspring of a Proband with BWS Based on Family History and Molecular Mechanism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.T.risk_to_offspring_of_a_proband_wit/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.T.risk_to_offspring_of_a_proband_wit_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">BWS Molecular Mechanism</th><th id="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Risk to Offspring of a Proband</th></tr></thead><tbody><tr><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2</td><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low in the absence of a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality as the imprint normally is reset in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; empiric data not yet available&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC1</td><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Theoretically low in the absence of a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormality as the imprint normally is reset in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; empiric data not yet available</td></tr><tr><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></td><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>: 50%<br />Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>: &#x0003c;50%, but too few cases reported to generate a risk figure</td></tr><tr><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11p15.5 paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a></td><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Likely very low; however, empiric data not yet available</td></tr><tr><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11p15.5 microdeletion/microduplication</td><td headers="hd_h_bws.T.risk_to_offspring_of_a_proband_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%&#x000a0;<sup>2</sup><br />Phenotype in offspring could be BWS or <a href="/books/n/gene/rss/">Silver-Russell syndrome</a> depending on the sex of the transmitting parent&#x000a0;<sup>3</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bws.TF.4.1"><p class="no_margin"><a class="bk_pop" href="#bws.REF.niemitz.2004.844">Niemitz et al [2004]</a></p></div></dd><dt>2. </dt><dd><div id="bws.TF.4.2"><p class="no_margin">Microdeletions at IC1 and rarely microduplication at IC2 have been reported in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases [<a class="bk_pop" href="#bws.REF.hatada.1997.681">Hatada et al 1997</a>, <a class="bk_pop" href="#bws.REF.lee.1997.304">Lee et al 1997</a>, <a class="bk_pop" href="#bws.REF.sparago.2004.958">Sparago et al 2004</a>, <a class="bk_pop" href="#bws.REF.weksberg.2004">Weksberg &#x00026; Shuman 2004</a>, <a class="bk_pop" href="#bws.REF.cooper.2005.1025">Cooper et al 2005</a>, <a class="bk_pop" href="#bws.REF.prawitt.2005.4085">Prawitt et al 2005</a>, <a class="bk_pop" href="#bws.REF.enklaar.2006.1">Enklaar et al 2006</a>, <a class="bk_pop" href="#bws.REF.percesepe.2008.447">Percesepe et al 2008</a>, <a class="bk_pop" href="#bws.REF.scott.2008b.106">Scott et al 2008b</a>, <a class="bk_pop" href="#bws.REF.bliek.2009.611">Bliek et al 2009</a>].</p></div></dd><dt>3. </dt><dd><div id="bws.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#bws.REF.sparago.2004.958">Sparago et al [2004]</a></p></div></dd></dl></div></div></div><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the molecular etiology.</p></div><div id="bws.Risk_to_Family_Members_of_a_Proband_1"><h3>Risk to Family Members of a Proband with a Chromosome Abnormality</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Parents of a proband with a structural balanced or unbalanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> constitution are at risk of having a balanced chromosome rearrangement and should be offered chromosome analysis.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormality</b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> findings in the parents.</div></li><li class="half_rhythm"><div>For mothers carrying a balanced 11p15 <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> may be as high as 50% and the BWS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> appears to segregate with maternal transmission of this translocation.</div></li><li class="half_rhythm"><div>For fathers carrying a balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> involving <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15 who have an offspring with an 11p <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> is increased but an exact figure is not available.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormality.</b> The risk may be as high as 50% if the proband is a female. For a male proband, the risk is expected to be low.</p><div id="bws.T.risk_to_sibs_and_offspring_of_a_pr" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Risk to Sibs and Offspring of a Proband with BWS and a Cytogenetic Abnormality</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.T.risk_to_sibs_and_offspring_of_a_pr/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.T.risk_to_sibs_and_offspring_of_a_pr_lrgtbl__"><table><thead><tr><th id="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cytogenetic Abnormality</th><th id="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Risk to Sibs of a Proband</th><th id="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Risk to Offspring</th></tr></thead><tbody><tr><td headers="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cytogenetically detected maternal 11p15 <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> or inversion</td><td headers="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be as high as 50% if the transmitting parent is a female</td><td headers="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be as high as 50% if the transmitting parent is a female</td></tr><tr><td headers="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cytogenetically detected paternal 11p15 <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a></td><td headers="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not defined</td><td headers="hd_h_bws.T.risk_to_sibs_and_offspring_of_a_pr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not defined</td></tr></tbody></table></div></div><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Whenever a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormality is identified, other at-risk family members should be offered chromosome testing to clarify their status.</p></div><div id="bws.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#bws.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> regarding prenatal testing is before pregnancy. Decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or who carry <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> alterations that increase their risk (e.g., a normal female who has inherited a balanced 11p15 <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> from her father).</div></li></ul><p><b>Possible <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> risks associated with assisted reproductive technology (ART).</b> Data have suggested the possibility of a link between subfertility/ART and imprinting disorders [<a class="bk_pop" href="#bws.REF.debaun.2002.604">DeBaun et al 2002</a>, <a class="bk_pop" href="#bws.REF.maher.2003a.2508">Maher et al 2003a</a>, <a class="bk_pop" href="#bws.REF.maher.2003b.62">Maher et al 2003b</a>]. More recently <a class="bk_pop" href="#bws.REF.debaun.2003.156">DeBaun et al [2003]</a>, <a class="bk_pop" href="#bws.REF.gicquel.2003.1338">Gicquel et al [2003]</a>, <a class="bk_pop" href="#bws.REF.maher.2003a.2508">Maher et al [2003a]</a>, and <a class="bk_pop" href="#bws.REF.halliday.2004.526">Halliday et al [2004]</a> reported data suggesting that ART may favor imprinting alterations at the centromeric <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> 11p15 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> IC2 and, thus, may increase the incidence of BWS in the offspring of couples who are subfertile and/or women undergoing ART procedures. It is unknown what role the underlying issues of subfertility as opposed to the ART procedures play in causing these imprinting defects.</p><p>The preimplantation phase of embryonic development is a critical time for imprint maintenance. Although no specific procedures of ART have been shown to increase the risk of Beckwith-Wiedemann syndrome, many procedures involved in ART may influence <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> including the ovarian follicle stimulation protocol, the biologic technique, the stage of maturation of the gametes, the culture media, and the timing of embryo transfer.</p><p>Reports of <a href="/books/n/gene/angelman/">Angelman syndrome</a> associated with ART suggest that epigenetic errors in early development are not confined to Beckwith-Wiedemann syndrome.</p><p>These data, although retrospective, highlight the need for follow up of children born after ART and for larger prospective studies to clarify whether a significant increase in the risk of <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> errors is associated with ART and if so, whether this finding is associated with ART procedures alone or with the underlying subfertility of the parents [<a class="bk_pop" href="#bws.REF.debaun.2003.156">DeBaun et al 2003</a>, <a class="bk_pop" href="#bws.REF.gicquel.2003.1338">Gicquel et al 2003</a>, <a class="bk_pop" href="#bws.REF.gosden.2003.1975">Gosden et al 2003</a>, <a class="bk_pop" href="#bws.REF.maher.2003a.2508">Maher et al 2003a</a>, <a class="bk_pop" href="#bws.REF.weksberg.2003.r61">Weksberg et al 2003</a>, <a class="bk_pop" href="#bws.REF.schieve.2004.1154">Schieve et al 2004</a>, <a class="bk_pop" href="#bws.REF.weksberg.2005.12">Weksberg et al 2005</a>].</p><p><b>Monozygotic twinning.</b> Monozygotic twins discordant for BWS (usually females) have been shown to also be discordant for loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 in skin fibroblasts but variably concordant in blood cells, probably as a result of shared fetal circulation [<a class="bk_pop" href="#bws.REF.weksberg.2002.1317">Weksberg et al 2002</a>]. Male monozygotic twins are much less frequently observed and demonstrate additional molecular findings including UPD for 11p15 and gain of methylation at IC1. As no recurrences are reported in the sibs of these twins, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> is not known.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bws.Prenatal_Testing"><h3>Prenatal Testing</h3><p><b>Positive family history.</b> A number of options exist for families who have had one child with BWS and are interested in <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a>. Some families may wish to consider prenatal testing for management of the pregnancy and delivery; others may consider pregnancy termination.</p><p>If a <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> or molecular genetic abnormality has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, appropriate testing of the pregnancy at risk is possible.</p><p>Genomic alterations including duplications/deletions involving 11p15 or pathogenic <i>CDKN1C</i> variants can be detected via analysis of fetal DNA from samples obtained by CVS or amniocentesis. However, DNA extracted from amniotic fluid is currently felt to provide the most reliable tissue source for evaluating fetal <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> status, although false negative findings have been reported [<a class="bk_pop" href="#bws.REF.eggermann.2015.77">Eggermann et al 2015</a>]. Cultured amniocytes may demonstrate clonal findings that are not representative of the fetal status, similar to postnatal testing issues related to <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>. Similarly, tissue obtained via CVS for prenatal testing for methylation status may not yield reliable results; a false positive test has been reported [<a class="bk_pop" href="#bws.REF.eggermann.2015.77">Eggermann et al 2015</a>]. This latter issue reflects the timing of methylation establishment in early placental development. Genetic counseling regarding the potential limitations of prenatal testing for epigenetic alterations should be undertaken [<a class="bk_pop" href="#bws.REF.eggermann.2015.77">Eggermann et al 2015</a>].</p><p>For all pregnancies at increased risk for BWS, whether or not the genetic mechanism is known:</p><ul><li class="half_rhythm"><div>Maternal serum alpha-fetoprotein (AFP) concentration may be elevated at 16 weeks' gestation in the presence of omphalocele.</div></li><li class="half_rhythm"><div>Ultrasound examination can be performed at 19-20 weeks' gestation and again at 25-32 weeks' gestation to assess growth parameters that may become advanced for gestational age late in the second trimester and to detect abdominal wall defects, organomegaly, renal anomalies, cleft palate, cardiac abnormalities, and macroglossia. In one report, ultrasound examination performed between ten and 14 weeks' gestation revealed increased nuchal thickness and omphalocele in a fetus later found to have BWS [<a class="bk_pop" href="#bws.REF.souka.1998.391">Souka et al 1998</a>].</div></li></ul><p>Note: (1) If ultrasound examination does not show malformations or abnormalities of fetal growth, a residual risk for recurrence of BWS remains, given the variability in clinical presentation. (2) Even in the absence of obvious clinical findings on prenatal investigation, the newborn should be monitored for hypoglycemia.</p><p><b>Negative family history.</b> In pregnancies in which there is no family history of BWS, but an abnormality such as apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> omphalocele is detected on ultrasound examination, additional investigations that should be considered [<a class="bk_pop" href="#bws.REF.porter.2009.668">Porter et al 2009</a>, <a class="bk_pop" href="#bws.REF.wilkinshaug.2009.58">Wilkins-Haug et al 2009</a>] include the following:</p><ul><li class="half_rhythm"><div>Molecular genetic testing for <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> alterations in amniocytes; if no methylation alteration is identified, testing for a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li><li class="half_rhythm"><div>Chromosomal microarray for copy number variants involving <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15 and/or <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> testing to evaluate for duplications, inversions, or translocations involving 11p15</div></li><li class="half_rhythm"><div>Serial ultrasound examinations to assess fetal growth and to detect other abnormalities characteristic of BWS</div></li></ul><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements. Molecular genetic testing can be offered if there is a high index of suspicion for BWS.</p></div></div><div id="bws.Resources"><h2 id="_bws_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Beckwith-Wiedemann Children's Foundation International</b></div><div><a href="http://beckwithwiedemann.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.beckwithwiedemann.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Beckwith-Wiedemann%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Beckwith-Wiedemann syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/beckwith-wiedemann-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Beckwith-Wiedemann syndrome</a></div></li></ul></div><div id="bws.Molecular_Genetics"><h2 id="_bws_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bws.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Beckwith-Wiedemann Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Critical Region</th><th id="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">BWS</td><td headers="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">11p15.4</td><td headers="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1028" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CDKN1C</i></a></td><td headers="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1028" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.4</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P49918" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cyclin-dependent kinase inhibitor 1C</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CDKN1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDKN1C database</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CDKN1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDKN1C</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CDKN1C[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDKN1C</a></td></tr><tr><td headers="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/283120" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>H19</i></a></td><td headers="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=283120" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.5</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/H19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">H19 @ LOVD</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=H19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">H19</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=H19[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">H19</a></td></tr><tr><td headers="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3481" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>IGF2</i></a></td><td headers="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3481" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.5</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P01344" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Insulin-like growth factor II</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/IGF2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LOVD - Growth Consortium (IGF2)</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=IGF2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IGF2</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=IGF2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IGF2</a></td></tr><tr><td headers="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3784" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNQ1</i></a></td><td headers="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3784" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.5-p15.4</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51787" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily KQT member 1</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1 @ LOVD</a><br /><a href="https://lovd.nl/KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1 @ ZAC-GGM</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNQ1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1</a></td></tr><tr><td headers="hd_b_bws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_bws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10984" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNQ1OT1</i></a></td><td headers="hd_b_bws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10984" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.5</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_bws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNQ1OT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1OT1 @ LOVD</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNQ1OT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1OT1</a></td><td headers="hd_b_bws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNQ1OT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1OT1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bws.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bws.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Beckwith-Wiedemann Syndrome (<a href="/omim/103280,130650,147470,600856,604115,607542,616186" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1394/table/bws.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bws.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/103280" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">103280</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H19, IMPRINTED MATERNALLY EXPRESSED NONCODING TRANSCRIPT; H19</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/130650" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">130650</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BECKWITH-WIEDEMANN SYNDROME; BWS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/147470" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">147470</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INSULIN-LIKE GROWTH FACTOR II; IGF2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600856" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600856</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYCLIN-DEPENDENT KINASE INHIBITOR 1C; CDKN1C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604115" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604115</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KCNQ1-OVERLAPPING TRANSCRIPT 1; KCNQ1OT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607542" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607542</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616186" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616186</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H19/IGF2-IMPRINTING CONTROL REGION</td></tr></tbody></table></div></div><div id="bws.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Imprinting</b> is an epigenetic process whereby the DNA of the two alleles of a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is differentially modified so that only one parental <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, parent-specific for each gene, is normally expressed [<a class="bk_pop" href="#bws.REF.barlow.1994.194">Barlow 1994</a>]. Imprinted genes cluster to distinct domains in the genome and an <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center controls resetting of a group of closely linked <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes during transmission through the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> [<a class="bk_pop" href="#bws.REF.nicholls.1994.733">Nicholls 1994</a>].</p><p><b>Gene/<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>.</b> A number of candidate <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes including growth factors and tumor suppressor genes mapping to the 11p15 region have been implicated. Imprinting centers (IC1 and IC2) control <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression across large chromosomal domains. Many different molecular alterations in this region occur in association with Beckwith-Wiedemann syndrome (BWS).</p><p><b>Alterations of <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression associated with BWS.</b> There are two imprinted domains in the BWS <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> (see <a class="figpopup" href="/books/NBK1394/figure/bws.F1/?report=objectonly" target="object" rid-figpopup="figbwsF1" rid-ob="figobbwsF1">Figure 1a</a>).</p><p>Domain 1 is telomeric and contains the <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes <i>H19</i> and <i>IGF2</i>. <i>H19</i> is a noncoding, nontranslated RNA that may function as a tumor suppressor. <i>IGF2</i> is a potent fetal growth factor. <i>H19</i> and <i>IGF2</i> are reciprocally expressed imprinted genes with <i>H19</i> maternally expressed and <i>IGF2</i> paternally expressed. The expression of this <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is regulated by an <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center upstream of <i>H19</i> called imprinting center 1 (IC1) (also known as differentially methylated region 1 [DMR1]). IC1 is normally methylated on the paternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and unmethylated on the maternal allele. Regulation of transcription is accomplished by binding of the zinc-finger insulator protein CTCF to its consensus sequence within IC1. CTCF only binds to unmethylated sequence (maternal allele) and interferes with downstream enhancers interacting with the <i>IGF2</i> promoters [<a class="bk_pop" href="#bws.REF.hark.2000.486">Hark et al 2000</a>].</p><p>Domain 2 is located centromerically and contains the <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes <i>CDKN1C</i>, <i>KCNQ1</i>, and <i>KCNQ1OT1</i>. Regulation of this <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is controlled by <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 2 (IC2) (previously known as differentially methylated region2 [DMR2]). IC2 is located in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 10 of <i>KCNQ1</i>. IC2 [<a class="bk_pop" href="#bws.REF.smilinich.1999.8064">Smilinich et al 1999</a>] contains the promoter for <i>KCNQ1OT1</i> &#x02013; a noncoding RNA with potential regulatory function [<a class="bk_pop" href="#bws.REF.pandey.2008.232">Pandey et al 2008</a>]. Although the exact regulation of this region is not clear it is known that loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC2 on the maternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> results in <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> expression of the normally paternally expressed <i>KCNQ1OT1</i>. Additionally, it has been shown that individuals with BWS and loss of methylation at IC2 on the maternal chromosome have reduced <i>CDKN1C</i> expression [<a class="bk_pop" href="#bws.REF.diazmeyer.2003.797">Diaz-Meyer et al 2003</a>].</p><p>An <b><a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center (IC)</b> is a region of DNA that can regulate in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> the expression of neighboring <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes over large distances. ICs are usually characterized by differential DNA <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> and differential histone modifications and may also be referred to as imprinting control regions (ICRs) or differentially methylated regions (DMRs).</p><ul><li class="half_rhythm"><div><b>IC1</b> is the telomeric <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5 that maps upstream of the <i>H19</i> promoter and regulates <i>H19</i> and <i>IGF2</i>. It may also be referred to as ICR1, DMR1, or H19DMR. It is normally methylated on the paternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and unmethylated on the maternal allele (i.e., differentially methylated).</div></li><li class="half_rhythm"><div><b>IC2</b> is the centromeric <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center that regulates several genes including <i>KCNQ1OT1</i>, <i>KCNQ1</i>, and <i>CDKN1C</i>. It may also be referred to as ICR2, DMR2, or KvDMR1. It is normally methylated on the maternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and unmethylated on the paternal allele (i.e., differentially methylated).</div></li><li class="half_rhythm"><div>Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> or hypermethylation &#x02013; increased level of DNA methylation compared to control samples. For <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> regions this may be associated with methylation of a normally unmethylated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div>Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> or hypomethylation &#x02013; decreased level of DNA methylation compared to control samples. For <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> regions, this may be associated with loss of methylation of a normally methylated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div><b>Uniparental disomy (UPD).</b> In BWS, <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for 11p15 UPD is found in 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. The UPD appears to consistently arise from a somatic <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> event resulting in paternal isodisomy. Most UPD cases demonstrate segmental mosaicism for paternal UPD for 11p15, suggesting that the underlying mechanism is a postzygotic somatic recombination event resulting in mosaicism for UPD of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15. Therefore, UPD may not be detected if a low level of mosaicism occurs in the tissue sampled. Testing of other tissues (e.g., skin fibroblasts, tumor biopsy) should be considered.</div></li><li class="half_rhythm"><div><b><i>IGF2</i></b> is an <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding a paternally expressed embryonic growth factor. Disruption of <i>IGF2</i> <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> resulting in <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> expression has been observed in some individuals with BWS as well as in multiple tumors, including Wilms tumor. Mice with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the paternally derived <i>igf2</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> are small at birth whereas the same pathogenic variant in the maternally inherited allele does not affect fetal growth. Also, overgrowth of mice is seen with overexpression of <i>igf2</i> or disruption of the <i>Iigf2</i> receptor.</div></li><li class="half_rhythm"><div><b><i>H19</i>.</b> This maternally expressed <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encodes a biologically active noncoding <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> that may function as a tumor suppressor. Approximately 50% of individuals with BWS exhibit <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>IGF2</i> expression in their tissues demonstrating uncoupled expression of <i>IGF2</i> and <i>H19</i>; that is, most retain normal maternal monoallelic expression of <i>H19.</i> Less commonly, changes in <i>H19</i> expression or <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> are reported in individuals with BWS [<a class="bk_pop" href="#bws.REF.joyce.1997.1543">Joyce et al 1997</a>, <a class="bk_pop" href="#bws.REF.sparago.2004.958">Sparago et al 2004</a>].</div></li><li class="half_rhythm"><div><b><i>CDKN1C</i></b> encodes the protein p57<sup>KIP2</sup>, a member of the cyclin-dependent kinase inhibitor family which acts to negatively regulate cell proliferation. This <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is both a putative tumor suppressor gene and a potential negative regulator of fetal growth. Both of these functions and the preferential maternal expression (incomplete repression of transcription of the paternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>) of this gene suggested it as a candidate gene for BWS. Pathogenic variants in this gene have been reported in approximately 5% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. <i>CDKN1C</i> pathogenic variants are found more frequently in individuals with omphalocele, cleft palate, and a positive family history. However, not all instances of vertical transmission of BWS can currently be ascribed to pathogenic variants in <i>CDKN1C</i> [<a class="bk_pop" href="#bws.REF.hatada.1997.681">Hatada et al 1997</a>, <a class="bk_pop" href="#bws.REF.lee.1997.304">Lee et al 1997</a>].</div></li><li class="half_rhythm"><div><b><i>KCNQ1</i>.</b> The protein encoded by <i>KCNQ1</i> forms part of a potassium channel and has also been implicated in at least two cardiac arrhythmia syndromes, <a href="/books/n/gene/rws/">Romano-Ward syndrome</a> and <a href="/books/n/gene/jln/">Jervell and Lange-Nielsen syndrome</a>. This <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is maternally expressed in most tissues (excluding the heart) and has four alternatively spliced transcripts, two of which are untranslated.</div></li><li class="half_rhythm"><div><b><i>KCNQ1OT1</i></b> is an anti-sense transcript which originates in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 10 of <i>KCNQ1</i>. Loss of <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> occurs in the 5' differentially methylated <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> (IC2) of <i>KCNQ1OT1</i> in 50% of individuals with BWS [<a class="bk_pop" href="#bws.REF.bliek.2001.467">Bliek et al 2001</a>, <a class="bk_pop" href="#bws.REF.weksberg.2001.2989">Weksberg et al 2001</a>].</div></li></ul><p><b>Other <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes.</b>
<i>PHLDA2</i> (also known as <i>IPL</i>, <i>HLDA2</i>, or <i>BWR1C</i>) and <i>SLC22A18</i> (also known as <i>TSSC5</i>, <i>BWR1A</i>, or <i>ITM</i>) are imprinted genes in the 11p15 region [<a class="bk_pop" href="#bws.REF.qian.1997.2021">Qian et al 1997</a>, <a class="bk_pop" href="#bws.REF.dao.1998.597">Dao et al 1998</a>]. Both genes show preferential maternal expression in fetal life and are located centromeric to <i>CDKN1C</i>. While neither <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has been directly implicated in BWS, both are hypothesized to have negative growth regulatory functions. Recently, <i>PHLDA2</i> has been shown to be important for normal placental/fetal development [<a class="bk_pop" href="#bws.REF.d_ria.2010.444">D&#x000f3;ria et al 2010</a>, <a class="bk_pop" href="#bws.REF.tunster.2010.295">Tunster et al 2010</a>].</p><p>Dosage of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression in this region is important for the regulation of fetal growth in mice. Upregulation of <i>Igf2</i> expression and downregulation of <i>Cdkn1c</i> (p57<sup>Kip2</sup>) result in phenotypes analogous to BWS in mouse models [<a class="bk_pop" href="#bws.REF.caspary.1999.3115">Caspary et al 1999</a>].</p></div></div><div id="bws.References"><h2 id="_bws_References_">References</h2><div id="bws.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bws.REF.shaffer.2001">Shaffer LG, Agan N, Goldberg JD, Ledbetter DH, Longshore JW, Cassidy SB. American College of Medical Genetics statement of diagnostic testing for uniparental disomy. Available <a href="/pmc/articles/PMC3111049/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2001. Accessed 10-21-19.</div></li></ul></div><div id="bws.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bws.REF.algar.2000.497">Algar E, Brickell S, Deeble G, Amor D, Smith P. Analysis of CDKN1C in Beckwith Wiedemann syndrome. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">15</span>:497–508.</span> [<a href="/pubmed/10862080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10862080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.alsultan.2008.695">Alsultan A, Lovell MA, Hayes KL, Allshouse MJ, Garrington TP. Simultaneous occurrence of right adrenocortical tumor and left adrenal neuroblastoma in an infant with Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2008;<span class="ref-vol">51</span>:695–8.</span> [<a href="/pubmed/18668518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18668518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.arboleda.2012.788">Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B, D&#x000e9;lot EC, Rodriguez-Fernandez IA, Braslavsky D, Bergad&#x000e1; I, Dell'Angelica EC, Nelson SF, Martinez-Agosto JA, Achermann JC, Vilain E. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:788–92.</span> [<a href="/pmc/articles/PMC3386373/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3386373</span></a>] [<a href="/pubmed/22634751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22634751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.barlow.1994.194">Barlow DP. Imprinting: a gamete's point of view. <span><span class="ref-journal">Trends Genet. </span>1994;<span class="ref-vol">10</span>:194–9.</span> [<a href="/pubmed/7864936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7864936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.baskin.2014.321">Baskin B, Choufani S, Chen YA, Shuman C, Parkinson N, Lemyre E, Micheil Innes A, Stavropoulos DJ, Ray PN, Weksberg R. High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Hum Genet. </span>2014;<span class="ref-vol">133</span>:321–30.</span> [<a href="/pubmed/24154661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24154661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.baujat.2004.715">Baujat G, Rio M, Rossignol S, Sanlaville D, Lyonnet S, Le Merrer M, Munnich A, Gicquel C, Cormier-Daire V, Colleaux L. Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:715–20.</span> [<a href="/pmc/articles/PMC1181947/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181947</span></a>] [<a href="/pubmed/14997421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14997421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.beckwith.1998.268">Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">79</span>:268–73.</span> [<a href="/pubmed/9781906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9781906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.bliek.2001.467">Bliek J, Maas SM, Ruijter JM, Hennekam RC, Alders M, Westerveld A, Mannens MM. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:467–76.</span> [<a href="/pubmed/11181570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11181570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.bliek.2009.611">Bliek J, Verde G, Callaway J, Maas SM, De Crescenzo A, Sparago A, Cerrato F, Russo S, Ferraiuolo S, Rinaldi MM, Fischetto R, Lalatta F, Giordano L, Ferrari P, Cubellis MV, Larizza L, Temple IK, Mannens MM, Mackay DJ, Riccio A. Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:611–9.</span> [<a href="/pmc/articles/PMC2986258/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986258</span></a>] [<a href="/pubmed/19092779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19092779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.borer.1999.235">Borer JG, Kaefer M, Barnewolt CE, Elias ER, Hobbs N, Retik AB, Peters CA. Renal findings on radiological followup of patients with Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Urol. </span>1999;<span class="ref-vol">161</span>:235–9.</span> [<a href="/pubmed/10037413" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10037413</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.brioude.2015.894">Brioude F, Netchine I, Praz F, Le Jule M, Calmel C, Lacombe D, Edery P, Catala M, Odent S, Isidor B, Lyonnet S, Sigaudy S, Leheup B, Audebert-Bellanger S, Burglen L, Giuliano F, Alessandri JL, Cormier-Daire V, Laffargue F, Blesson S, Coupier I, Lespinasse J, Blanchet P, Boute O, Baumann C, Polak M, Doray B, Verloes A, Viot G, Le Bouc Y, Rossignol S. Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional Characterization. <span><span class="ref-journal">Hum Mutat. </span>2015;<span class="ref-vol">36</span>:894–902.</span> [<a href="/pubmed/26077438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26077438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.brioude.2013.823">Brioude F, Oliver-Petit I, Blaise A, Praz F, Rossignol S, Le Jule M, Thibaud N, Faussat AM, Tauber M, Le Bouc Y, Netchine I. CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:823–30.</span> [<a href="/pubmed/24065356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24065356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.caspary.1999.3115">Caspary T, Cleary MA, Perlman EJ, Zhang P, Elledge SJ, Tilghman SM. Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Genes Dev. </span>1999;<span class="ref-vol">13</span>:3115–24.</span> [<a href="/pmc/articles/PMC317182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC317182</span></a>] [<a href="/pubmed/10601037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10601037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.chitayat.1990.434">Chitayat D, Rothchild A, Ling E, Friedman JM, Couch RM, Yong SL, Baldwin VJ, Hall JG. Apparent postnatal onset of some manifestations of the Wiedemann-Beckwith syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">36</span>:434–9.</span> [<a href="/pubmed/2389800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2389800</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.choufani.2010.343">Choufani S, Shuman C, Weksberg R. Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2010;<span class="ref-vol">154C</span>:343–54.</span> [<a href="/pubmed/20803657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20803657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.choyke.1998.733">Choyke PL, Siegel MJ, Oz O, Sotelo-Avila C, DeBaun MR. Nonmalignant renal disease in pediatric patients with Beckwith-Wiedemann syndrome. <span><span class="ref-journal">AJR Am J Roentgenol. </span>1998;<span class="ref-vol">171</span>:733–7.</span> [<a href="/pubmed/9725306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9725306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.clericuzio.2003.270">Clericuzio CL, Chen E, McNeil DE, O'Connor T, Zackai EH, Medne L, Tomlinson G, DeBaun M. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. <span><span class="ref-journal">J Pediatr. </span>2003;<span class="ref-vol">143</span>:270–2.</span> [<a href="/pubmed/12970646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12970646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.clericuzio.2009.220">Clericuzio CL, Martin RA. Diagnostic criteria and tumor screening for individuals with isolated hemiphyperplasia. <span><span class="ref-journal">Genet Med. </span>2009;<span class="ref-vol">11</span>:220–2.</span> [<a href="/pmc/articles/PMC3111026/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3111026</span></a>] [<a href="/pubmed/19367194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19367194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.cohen.2005.287">Cohen MM Jr. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. <span><span class="ref-journal">Pediatr Dev Pathol. </span>2005;<span class="ref-vol">8</span>:287–304.</span> [<a href="/pubmed/16010495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16010495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.cooper.2005.1025">Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, Bowdin SC, Riccio A, Sebastio G, Bliek J, Schofield PN, Reik W, Macdonald F, Maher ER. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2005;<span class="ref-vol">13</span>:1025–32.</span> [<a href="/pubmed/15999116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15999116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.dao.1998.597">Dao D, Frank D, Qian N, O'Keefe D, Vosatka RJ, Walsh CP, Tycko B. IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:597–608.</span> [<a href="/pubmed/9499412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9499412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.debaun.2003.156">DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:156–60.</span> [<a href="/pmc/articles/PMC378620/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378620</span></a>] [<a href="/pubmed/12439823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12439823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.debaun.2002.604">DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:604–11.</span> [<a href="/pmc/articles/PMC384940/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384940</span></a>] [<a href="/pubmed/11813134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11813134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.diazmeyer.2003.797">Diaz-Meyer N, Day CD, Khatod K, Maher ER, Cooper W, Reik W, Junien C, Graham G, Algar E, Der Kaloustian VM, Higgins MJ. Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:797–801.</span> [<a href="/pmc/articles/PMC1735305/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735305</span></a>] [<a href="/pubmed/14627666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14627666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.d_ria.2010.444">D&#x000f3;ria S, Sousa M, Fernandes S, Ramalho C, Brand&#x000e3;o O, Matias A, Barros A, Carvalho F. Gene expression pattern of IGF2, PHLDA2, PEG10 and CDKN1C imprinted genes in spontaneous miscarriages or fetal deaths. <span><span class="ref-journal">Epigenetics. </span>2010;<span class="ref-vol">5</span>:444–50.</span> [<a href="/pubmed/20484977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20484977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.eggermann.2009.30">Eggermann T. Silver-Russell and Beckwith-Wiedemann syndromes: opposite (epi)mutations in 11p15 result in opposite clinical pictures. <span><span class="ref-journal">Horm Res. </span>2009;<span class="ref-vol">71</span> Suppl 2:30–5.</span> [<a href="/pubmed/19407494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19407494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.eggermann.2015.77">Eggermann T, Soellner L, Buiting K, Kotzot D. Mosaicism and uniparental disomy in prenatal diagnosis. <span><span class="ref-journal">Trends Mol Med. </span>2015;<span class="ref-vol">21</span>:77–87.</span> [<a href="/pubmed/25547535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25547535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.enklaar.2006.1">Enklaar T, Zabel BU, Prawitt D. Beckwith&#x02013;Wiedemann syndrome: multiple molecular mechanisms. <span><span class="ref-journal">Expert Rev Mol Med. </span>2006;<span class="ref-vol">8</span>:1–19.</span> [<a href="/pubmed/16842655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16842655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.everman.2000.123">Everman DB, Shuman C, Dzolganovski B, O'riordan MA, Weksberg R, Robin NH. Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Pediatr. </span>2000;<span class="ref-vol">137</span>:123–7.</span> [<a href="/pubmed/10891834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10891834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.gardiner.2012.1388">Gardiner K, Chitayat D, Choufani S, Shuman C, Blaser S, Terespolsky D, Farrell S, Reiss R, Wodak S, Pu S, Ray PN, Baskin B, Weksberg R. Brain abnormalities in patients with Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:1388–94.</span> [<a href="/pubmed/22585446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22585446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.gicquel.2003.1338">Gicquel C, Gaston V, Mandelbaum J, Siffroi JP, Flahault A, Le Bouc Y. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1338–41.</span> [<a href="/pmc/articles/PMC1180288/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180288</span></a>] [<a href="/pubmed/12772698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12772698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.goldman.2003.206">Goldman M, Shuman C, Weksberg R, Rosenblum ND. Hypercalciuria in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Pediatr. </span>2003;<span class="ref-vol">142</span>:206–8.</span> [<a href="/pubmed/12584548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12584548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.gosden.2003.1975">Gosden R, Trasler J, Lucifero D, Faddy M. Rare congenital disorders, imprinted genes, and assisted reproductive technology. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1975–7.</span> [<a href="/pubmed/12801753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12801753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.greer.2008.1707">Greer KJ, Kirkpatrick SJ, Weksberg R, Pauli RM. Beckwith-Wiedemann syndrome in adults: observations from one family and recommendations for care. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1707–12.</span> [<a href="/pubmed/18546283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18546283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.halliday.2004.526">Halliday J, Oke K, Breheny S, Algar E, J, Amor D. Beckwith&#x02013;Wiedemann syndrome and IVF: a case &#x02013; control study. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:526–8.</span> [<a href="/pmc/articles/PMC1182036/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182036</span></a>] [<a href="/pubmed/15284956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15284956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.hark.2000.486">Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. <span><span class="ref-journal">Nature. </span>2000;<span class="ref-vol">405</span>:486–9.</span> [<a href="/pubmed/10839547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10839547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.hatada.1997.681">Hatada I, Nabetani A, Morisaki H, Xin Z, Ohishi S, Tonoki H, Niikawa N, Inoue M, Komoto Y, Okada A, Steichen E, Ohashi H, Fukushima Y, Nakayama M, Mukai T. New p57KIP2 mutations in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Hum Genet. </span>1997;<span class="ref-vol">100</span>:681–3.</span> [<a href="/pubmed/9341892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9341892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.hopsu.2003.1131">Hopsu E, Aarnisalo A, Pitkaranta A. Progressive stapedial fixation in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Arch Otolaryngol Head Neck Surg. </span>2003;<span class="ref-vol">129</span>:1131–4.</span> [<a href="/pubmed/14568801" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14568801</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.hoyme.1998.274">Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M. Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">79</span>:274–8.</span> [<a href="/pubmed/9781907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9781907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.ibrahim.2014.11">Ibrahim A, Kirby G, Hardy C, Dias RP, Tee L, Lim D, Berg J, MacDonald F, Nightingale P, Maher ER. Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects. <span><span class="ref-journal">Clin Epigenetics. </span>2014;<span class="ref-vol">6</span>:11.</span> [<a href="/pmc/articles/PMC4064264/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4064264</span></a>] [<a href="/pubmed/24982696" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24982696</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.inbarfeigenberg.2013.13">Inbar-Feigenberg M, Choufani S, Cytrynbaum C, Chen YA, Steele L, Shuman C, Ray PN, Weksberg R. Mosaicism for genome-wide paternal uniparental disomy with features of multiple imprinting disorders: diagnostic and management issues. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:13–20.</span> [<a href="/pubmed/23239666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23239666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.joyce.1997.1543">Joyce JA, Lam WK, Catchpoole DJ, Jenks P, Reik W, Maher ER, Schofield PN. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith- Wiedemann syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:1543–8.</span> [<a href="/pubmed/9285792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9285792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.kalish.2013.1929">Kalish JM, Conlin LK, Bhatti TR, Dubbs HA, Harris MC, Izumi K, Mostoufi-Moab S, Mulchandani S, Saitta S, States LJ, Swarr DT, Wilkens AB, Zackai EH, Zelley K, Bartolomei MS, Nichols KE, Palladino AA, Spinner NB, Deardorff MA. Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:1929–39.</span> [<a href="/pmc/articles/PMC4082120/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4082120</span></a>] [<a href="/pubmed/23804593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23804593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.kaltenbach.2013.78">Kaltenbach S, Capri Y, Rossignol S, Denjoy I, Soud&#x000e9;e S, Aboura A, Baumann C, Verloes A. Beckwith-Wiedemann syndrome and long QT syndrome due to familial-balanced translocation t(11;17)(p15.5;q21.3) involving the KCNQ1 gene. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:78–81.</span> [<a href="/pubmed/23061425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23061425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.kantaputra.2013.192">Kantaputra PN, Sittiwangkul R, Sonsuwan N, Romanelli V, Tenorio J, Lapunzina P. A novel mutation in CDKN1C in sibs with Beckwith-Wiedemann syndrome and cleft palate, sensorineural hearing loss, and supernumerary flexion creases. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:192–7.</span> [<a href="/pubmed/23197429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23197429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.keren.2013.546">Keren B, Chantot-Bastaraud S, Brioude F, Mach C, Fonteneau E, Azzi S, Depienne C, Brice A, Netchine I, Le Bouc Y, Siffroi JP, Rossignol S. SNP arrays in Beckwith-Wiedemann syndrome: an improved diagnostic strategy. <span><span class="ref-journal">Eur J Med Genet. </span>2013;<span class="ref-vol">56</span>:546–50.</span> [<a href="/pubmed/23892181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23892181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.kimura.2008.93">Kimura Y, Yasuhiro K, Kimura S. Anesthetic management of two cases of Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Anesth. </span>2008;<span class="ref-vol">22</span>:93–95.</span> [<a href="/pubmed/18306025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18306025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.kuroiwa.2009.e31">Kuroiwa M, Sakamoto J, Shimada A, Suzuki N, Hirato J, Park MJ, Sotomatsu M, Hayashi Y. Manifestation of alveolar rhabdomyosarcoma as primary cutaneous lesions in a neonate with Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Pediatr Surg. </span>2009;<span class="ref-vol">44</span>:e31–5.</span> [<a href="/pubmed/19302842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19302842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.lam.1999.518">Lam WW, Hatada I, Ohishi S, Mukai T, Joyce JA, Cole TR, Donnai D, Reik W, Schofield PN, Maher ER. Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype- phenotype correlation. <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:518–23.</span> [<a href="/pmc/articles/PMC1734395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734395</span></a>] [<a href="/pubmed/10424811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10424811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.lee.1997.304">Lee MP, DeBaun M, Randhawa G, Reichard BA, Elledge SJ, Feinberg AP. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61</span>:304–9.</span> [<a href="/pmc/articles/PMC1715913/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715913</span></a>] [<a href="/pubmed/9311734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9311734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.lew.2004.268">Lew JM, Fei YL, Aleck K, Blencowe BJ, Weksberg R, Sadowski PD. CDKN1C mutation in Wiedemann-Beckwith syndrome patients reduces RNA splicing efficiency and identifies a splicing enhancer. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">127A</span>:268–76.</span> [<a href="/pubmed/15150778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15150778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.li.2001.370">Li M, Squire J, Shuman C, Fei YL, Atkin J, Pauli R, Smith A, Nishikawa J, Chitayat D, Weksberg R. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations. <span><span class="ref-journal">Genomics. </span>2001;<span class="ref-vol">74</span>:370–6.</span> [<a href="/pubmed/11414765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11414765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.li.1998.253">Li M, Squire JA, Weksberg R. Molecular genetics of Wiedemann-Beckwith syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">79</span>:253–9.</span> [<a href="/pubmed/9781904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9781904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.maher.2003a.2508">Maher ER, Afnan M, Barratt CL. Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs? <span><span class="ref-journal">Hum Reprod. </span>2003a;<span class="ref-vol">18</span>:2508–11.</span> [<a href="/pubmed/14645164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14645164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.maher.2003b.62">Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, Cole TR, Macdonald F, Sampson JR, Barratt CL, Reik W, Hawkins MM. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). <span><span class="ref-journal">J Med Genet. </span>2003b;<span class="ref-vol">40</span>:62–4.</span> [<a href="/pmc/articles/PMC1735252/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735252</span></a>] [<a href="/pubmed/12525545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12525545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.martin.2005.129">Martin RA, Grange DK, Zehnbauer B, Debaun MR. LIT1 and H19 methylation defects in isolated hemihyperplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">134A</span>:129–31.</span> [<a href="/pubmed/15651076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15651076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.milani.2014.169">Milani D, Pezzani L, Tabano S, Miozzo M. Beckwith-Wiedemann and IMAGe syndromes: two very different diseases caused by mutations on the same gene. <span><span class="ref-journal">Appl Clin Genet. </span>2014;<span class="ref-vol">7</span>:169–75.</span> [<a href="/pmc/articles/PMC4173641/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4173641</span></a>] [<a href="/pubmed/25258553" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25258553</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.mussa.2016a.52">Mussa A, Di Candia S, Russo S, Catania S, De Pellegrin M, Di Luzio L, Ferrari M, Tortora C, Meazzini MC, Brusati R, Milani D, Zampino G, Montirosso R, Riccio A, Selicorni A, Cocchi G, Ferrero GB. Recommendations of the Scientific Committee of the Italian Beckwith-Wiedemann Syndrome Association on the diagnosis, management and follow-up of the syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2016a;<span class="ref-vol">59</span>:52–64.</span> [<a href="/pubmed/26592461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26592461</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.mussa.2012.397">Mussa A, Peruzzi L, Chiesa N, De Crescenzo A, Russo S, Melis D, Tarani L, Baldassarre G, Larizza L, Riccio A, Silengo M, Ferrero GB. Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Pediatr Nephrol. </span>2012;<span class="ref-vol">27</span>:397–406.</span> [<a href="/pubmed/22015620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22015620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.mussa.2013.2481">Mussa A, Russo S, De Crescenzo A, Chiesa N, Molinatto C, Selicorni A, Richiardi L, Larizza L, Silengo MC, Riccio A, Ferrero GB. Prevalence of Beckwith-Wiedemann syndrome in North West of Italy. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2481–6.</span> [<a href="/pubmed/23918458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23918458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.mussa.2016b.183">Mussa A, Russo S, De Crescenzo A, Freschi A, Calzari L, Maitz S, Macchiaiolo M, Molinatto C, Baldassarre G, Mariani M, Tarani L, Bedeschi MF, Milani D, Melis D, Bartuli A, Cubellis MV, Selicorni A, Cirillo Silengo M, Larizza L, Riccio A, Ferrero GB. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2016b;<span class="ref-vol">24</span>:183–90.</span> [<a href="/pmc/articles/PMC4717210/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4717210</span></a>] [<a href="/pubmed/25898929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25898929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.mussa.2016c.403">Mussa A, Russo S, Larizza L, Riccio A, Ferrero GB. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome: a paradigm for genomic medicine. <span><span class="ref-journal">Clin Genet. </span>2016c;<span class="ref-vol">89</span>:403–15.</span> [<a href="/pubmed/26138266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26138266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.nicholls.1994.733">Nicholls RD. New insights reveal complex mechanisms involved in genomic imprinting. <span><span class="ref-journal">Am J Hum Genet. </span>1994;<span class="ref-vol">54</span>:733–40.</span> [editorial; comment] [<a href="/pmc/articles/PMC1918270/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1918270</span></a>] [<a href="/pubmed/8178814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8178814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.niemitz.2004.844">Niemitz EL, DeBaun MR, Fallon J, Murakami K, Kugoh H, Oshimura M, Feinberg AP. Microdeletion of LIT1 in familial Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:844–9.</span> [<a href="/pmc/articles/PMC1182113/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182113</span></a>] [<a href="/pubmed/15372379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15372379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.okeefe.1997.295">O'Keefe D, Dao D, Zhao L, Sanderson R, Warburton D, Weiss L, Anyane-Yeboa K, Tycko B. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61</span>:295–303.</span> [<a href="/pmc/articles/PMC1715902/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715902</span></a>] [<a href="/pubmed/9311733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9311733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.pandey.2008.232">Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, Nagano T, Mancini-Dinardo D, Kanduri C. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. <span><span class="ref-journal">Mol Cell. </span>2008;<span class="ref-vol">32</span>:232–46.</span> [<a href="/pubmed/18951091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18951091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.percesepe.2008.447">Percesepe A, Bertucci E, Ferrari P, Lugli L, Ferrari F, Mazza V, Forabosco A. Familial Beckwith-Wiedemann syndrome due to CDKN1C mutation manifesting with recurring omphalocele. <span><span class="ref-journal">Prenat Diagn. </span>2008;<span class="ref-vol">28</span>:447–9.</span> [<a href="/pubmed/18395877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18395877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.pettenati.1986.143">Pettenati MJ, Haines JL, Higgins RR, Wappner RS, Palmer CG, Weaver DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. <span><span class="ref-journal">Hum Genet. </span>1986;<span class="ref-vol">74</span>:143–54.</span> [<a href="/pubmed/3770742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3770742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.porter.2009.668">Porter A, Benson CB, Hawley P, Wilkins-Haug L. Outcome of fetuses with a prenatal ultrasound diagnosis of isolated omphalocele. <span><span class="ref-journal">Prenat Diagn. </span>2009;<span class="ref-vol">29</span>:668–73.</span> [<a href="/pubmed/19367563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19367563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.prawitt.2005.4085">Prawitt D, Enklaar T, Gartner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, Zabel B. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:4085–90.</span> [<a href="/pmc/articles/PMC554791/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC554791</span></a>] [<a href="/pubmed/15743916" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15743916</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.qian.1997.2021">Qian N, Frank D, O'Keefe D, Dao D, Zhao L, Yuan L, Wang Q, Keating M, Walsh C, Tycko B. The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:2021–9.</span> [<a href="/pubmed/9328465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9328465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.rump.2005.95">Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith&#x02013;Wiedemann syndrome: a review and meta-analysis. <span><span class="ref-journal">Am J Med Genet. </span>2005;<span class="ref-vol">136</span>:95–104.</span> [<a href="/pubmed/15887271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15887271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.russo.2016.23">Russo S, Calzari L, Mussa A, Mainini E, Cassina M, Di Candia S, Clementi M, Guzzetti S, Tabano S, Miozzo M, Sirchia S, Finelli P, Prontera P, Maitz S, Sorge G, Calcagno A, Maghnie M, Divizia MT, Melis D, Manfredini E, Ferrero GB, Pecile V, Larizza L. A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes. <span><span class="ref-journal">Clin Epigenetics. </span>2016;<span class="ref-vol">8</span>:23.</span> [<a href="/pmc/articles/PMC4772365/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4772365</span></a>] [<a href="/pubmed/26933465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26933465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.sasaki.2007.1205">Sasaki K, Soejima H, Higashimoto K, Yatsuki H, Ohashi H, Yakabe S, Joh K, Niikawa N, Mukai T. Japanese and North American/European patients with Beckwith-Wiedemann syndrome have different frequencies of some epigenetic and genetic alterations. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:1205–10.</span> [<a href="/pubmed/17700627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17700627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.schieve.2004.1154">Schieve LA, Rasmussen SA, Buck GM, Schendel DE, Reynolds MA, Wright VC. Are children born after assisted reproductive technology at increased risk for adverse health outcomes? <span><span class="ref-journal">Obstet Gynecol. </span>2004;<span class="ref-vol">103</span>:1154–63.</span> [<a href="/pubmed/15172847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15172847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.scott.2008b.106">Scott RH, Douglas J, Baskcomb L, Nygren AO, Birch JM, Cole TR, Cormier-Daire V, Eastwood DM, Garcia-Minaur S, Lupunzina P, Tatton-Brown K, Bliek J, Maher ER, Rahman N. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. <span><span class="ref-journal">J Med Genet. </span>2008b;<span class="ref-vol">45</span>:106–13.</span> [<a href="/pubmed/18245390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18245390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.scott.2006.995">Scott RH, Walker L, Olsen &#x000d8;E, Levitt G, Kenney I, Maher E, Owens CM, Pritchard-Jones K, Craft A, Rahman N. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. <span><span class="ref-journal">Arch Dis Child. </span>2006;<span class="ref-vol">91</span>:995–9.</span> [<a href="/pmc/articles/PMC2083016/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2083016</span></a>] [<a href="/pubmed/16857697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16857697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.scott.2008a.1329">Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D, Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N, et al.  Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. <span><span class="ref-journal">Nat Genet. </span>2008a;<span class="ref-vol">40</span>:1329–34.</span> [<a href="/pubmed/18836444" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18836444</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.shuman.2002">Shuman C, Steele L, Fei YL, Ray PN, Zackai E, Parisi M, Squire J, Weksberg R. Paternal uniparental disomy of 11p15 is associated with isolated hemihyperplasia and expands Beckwith-Wiedemann syndrome spectrum. Am J Hum Genet 2002;71:A1800, 477.</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.slavotinek.1997.819">Slavotinek A, Gaunt L, Donnai D. Paternally inherited duplications of 11p15.5 and Beckwith-Wiedemann syndrome. <span><span class="ref-journal">J Med Genet. </span>1997;<span class="ref-vol">34</span>:819–26.</span> [<a href="/pmc/articles/PMC1051088/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051088</span></a>] [<a href="/pubmed/9350814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9350814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.smilinich.1999.8064">Smilinich NJ, Day CD, Fitzpatrick GV, Caldwell GM, Lossie AC, Cooper PR, Smallwood AC, Joyce JA, Schofield PN, Reik W, Nicholls RD, Weksberg R, Driscoll DJ, Maher ER, Shows TB, Higgins MJ. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1999;<span class="ref-vol">96</span>:8064–9.</span> [<a href="/pmc/articles/PMC22188/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC22188</span></a>] [<a href="/pubmed/10393948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10393948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.smith.2006.313">Smith AC, Rubin T, Shuman C, Estabrooks L, Aylsworth AS, McDonald MT, Steele L, Ray PN, Weksberg R. New chromosome 11p15 epigenotypes identified in male monozygotic twins with Beckwith&#x02013;Wiedemann syndrome. <span><span class="ref-journal">Cytogenet Genome Res. </span>2006;<span class="ref-vol">113</span>:313–7.</span> [<a href="/pubmed/16575195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16575195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.souka.1998.391">Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>1998;<span class="ref-vol">11</span>:391–400.</span> [<a href="/pubmed/9674084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9674084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.sparago.2004.958">Sparago A, Cerrato F, Vernucci M, Ferrero GB, Silengo MC, Riccio A. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:958–60.</span> [<a href="/pubmed/15314640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15314640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.tan.2006.486">Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. <span><span class="ref-journal">J Paediatr Child Health. </span>2006;<span class="ref-vol">42</span>:486–90.</span> [<a href="/pubmed/16925531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16925531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.thorburn.1970.316">Thorburn MJ, Wright ES, Miller CG, Smith-Read EH. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. <span><span class="ref-journal">Am J Dis Child. </span>1970;<span class="ref-vol">119</span>:316–21.</span> [<a href="/pubmed/5434588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5434588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.tomlinson.2007.992">Tomlinson JK, Morse SA, Bernard SP, Greensmith AL, Meara JG. Long-term outcomes of surgical tongue reduction in Beckwith&#x02013;Wiedemann syndrome. <span><span class="ref-journal">Plast Reconstr Surg. </span>2007;<span class="ref-vol">119</span>:992–1002.</span> [<a href="/pubmed/17312506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17312506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.tunster.2010.295">Tunster SJ, Tycko B, John RM. The imprinted Phlda2 gene regulates extraembryonic energy stores. <span><span class="ref-journal">Mol Cell Biol. </span>2010;<span class="ref-vol">30</span>:295–306.</span> [<a href="/pmc/articles/PMC2798284/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2798284</span></a>] [<a href="/pubmed/19884348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19884348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.van_eeghen.1999.187">van Eeghen AM, van Gelderen I, Hennekam RC. Costello syndrome: report and review. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">82</span>:187–93.</span> [<a href="/pubmed/9934987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9934987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.weksberg.2001.2989">Weksberg R, Nishikawa J, Caluseriu O, Fei YL, Shuman C, Wei C, Steele L, Cameron J, Smith A, Ambus I, Li M, Ray PN, Sadowski P, Squire J. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:2989–3000.</span> [<a href="/pubmed/11751681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11751681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.weksberg.2002.1317">Weksberg R, Shuman C, Caluseriu O, Smith AC, Fei YL, Nishikawa J, Stockley TL, Best L, Chitayat D, Olney A, Ives E, Schneider A, Bestor TH, Li M, Sadowski P, Squire J. Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:1317–25.</span> [<a href="/pubmed/12019213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12019213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.weksberg.2005.12">Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2005;<span class="ref-vol">137C</span>:12–23.</span> [<a href="/pubmed/16010676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16010676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.weksberg.2004">Weksberg R, Shuman C. Beckwith-Wiedemann syndrome and hemihypertrophy In: Cassidy SB, Allanson JE, eds. <em>Management of Genetic Syndromes.</em> 2 ed. Hoboken, New Jersey: John Wiley &#x00026; Sons; 2004:101-16.</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.weksberg.2003.r61">Weksberg R, Smith AC, Squire J, Sadowski P. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>(Spec No 1):R61–8.</span> [<a href="/pubmed/12668598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12668598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.wilkinshaug.2009.58">Wilkins-Haug L, Porter A, Hawley P, Benson CB. Isolated fetal omphalocele, Beckwith-Wiedemann syndrome, and assisted reproductive technologies. <span><span class="ref-journal">Birth Defects Res A Clin Mol Teratol. </span>2009;<span class="ref-vol">85</span>:58–62.</span> [<a href="/pubmed/19107956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19107956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.wilson.2008.137">Wilson M, Peters G, Bennetts B, McGillivray G, Wu ZH, Poon C, Algar E. The clinical phenotype of mosaicism for genome-wide paternal uniparental disomy: Two new reports. <span><span class="ref-journal">Am J Med Genet. </span>2008;<span class="ref-vol">146A</span>:137–148.</span> [<a href="/pubmed/18033734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18033734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.zarate.2009.1691">Zarate YA, Mena R, Martin LJ, Steele P, Tinkle BT, Hopkin RJ. Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1691–7.</span> [<a href="/pubmed/19610116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19610116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bws.REF.zeschnigk.2008.328">Zeschnigk M, Albrecht B, Buiting K, Kanber D, Eggermann T, Binder G, Gromoll J, Prott EC, Seland S, Horsthemke B. IGF2/H19 hypomethylation in Silver-Russell syndrome and isolated hemihypoplasia. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:328–34.</span> [<a href="/pubmed/18159214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18159214</span></a>]</div></li></ul></div></div><div id="bws.Chapter_Notes"><h2 id="_bws_Chapter_Notes_">Chapter Notes</h2><div id="bws.Acknowledgments"><h3>Acknowledgments</h3><p>Sanaa Choufani, Adam Smith, Khadine Wiltshire</p></div><div id="bws.Author_History"><h3>Author History</h3><p>J Bruce Beckwith, MD (2000-present)<br />Cheryl Shuman, MS, CGC (2000-present)<br />Adam C Smith, PhD; The Hospital for Sick Children (2000-2016)<br />Rosanna Weksberg, MD, PhD, FRCPC, FCCMG, FACMG (2000-present)</p></div><div id="bws.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 August 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 December 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 September 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 April 2003 (tk) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 March 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>28 July 1999 (cs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1394</span><span class="label">PMID: <a href="/pubmed/20301568" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301568</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/barth/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bscl/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1394&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1394/?report=reader">PubReader</a></li><li><a href="/books/NBK1394/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1394" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1394" style="display:none" title="Cite this Page"><div class="bk_tt">Shuman C, Beckwith JB, Weksberg R. Beckwith-Wiedemann Syndrome. 2000 Mar 3 [Updated 2016 Aug 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1394/pdf/Bookshelf_NBK1394.pdf">PDF version of this page</a> (913K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bws.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bws.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bws.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bws.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bws.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bws.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bws.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bws.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bws.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bws.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bws.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3784[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1028[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CDKN1C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10984[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ1OT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=283120[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">H19</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3481[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IGF2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1472410" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1472410" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1472410" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1472410" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24154661" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome.</a><span class="source">[Hum Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Baskin B, Choufani S, Chen YA, Shuman C, Parkinson N, Lemyre E, Micheil Innes A, Stavropoulos DJ, Ray PN, Weksberg R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Genet. 2014 Mar; 133(3):321-30. Epub 2013 Oct 24.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25898929" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.</a><span class="source">[Eur J Hum Genet. 2016]</span><div class="brieflinkpop offscreen_noflow">(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mussa A, Russo S, De Crescenzo A, Freschi A, Calzari L, Maitz S, Macchiaiolo M, Molinatto C, Baldassarre G, Mariani M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2016 Feb; 24(2):183-90. Epub 2015 Apr 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301499" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Silver-Russell Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Silver-Russell Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saal HM, Harbison MD, Netchine I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23719190" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders.</a><span class="source">[J Hum Genet. 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Soejima H, Higashimoto K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Hum Genet. 2013 Jul; 58(7):402-9. Epub 2013 May 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23153226" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine.</a><span class="source">[J Biomed Sci. 2012]</span><div class="brieflinkpop offscreen_noflow">Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robbins KM, Chen Z, Wells KD, Rivera RM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Biomed Sci. 2012 Nov 15; 19:95. Epub 2012 Nov 15.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301568" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301568" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc94c0dde0891169dfea85">Beckwith-Wiedemann Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Beckwith-Wiedemann Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:30:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DC5CCDFC81A7100000000093E044C&amp;ncbi_session=CE8DC5CCDFC94C01_2366SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1394%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1394&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1394/&amp;ncbi_pagename=Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DC5CCDFC94C01_2366SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>